data_1e8q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1e8q _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.341 0.591 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.619 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 6.2 p-90 -76.72 -31.0 56.88 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.192 -0.943 . . . . 0.0 109.685 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.555 ' N ' ' CE3' ' A' ' 4' ' ' TRP . . . -57.99 -23.06 52.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 109.309 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.528 ' CG ' ' N ' ' A' ' 7' ' ' SER . 7.6 pt20 -54.14 -45.15 71.91 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.254 -0.904 . . . . 0.0 110.174 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.528 ' N ' ' CG ' ' A' ' 6' ' ' GLN . 28.0 t -43.36 -35.89 1.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 0.0 109.777 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -89.98 -35.56 15.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.862 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.21 20.65 2.68 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.309 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.445 ' CD2' ' HZ3' ' A' ' 30' ' ' TRP . 39.9 m-85 -94.11 169.67 10.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.937 -1.331 . . . . 0.0 109.081 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 0.9 OUTLIER -81.44 -151.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.051 -1.031 . . . . 0.0 110.845 -178.54 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.473 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 33.3 m -145.39 134.92 23.25 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.519 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 5.3 m -75.21 131.85 40.7 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.152 -0.968 . . . . 0.0 110.434 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -70.84 130.42 41.62 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 49.88 84.49 0.2 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.083 -1.011 . . . . 0.0 108.704 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 34.2 Cg_endo -76.99 -16.4 15.98 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.736 2.291 . . . . 0.0 110.831 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -1.55 15.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.925 . . . . 0.0 109.964 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 m -143.79 29.38 1.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.02 -1.05 . . . . 0.0 109.99 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 19' ' ' THR . 2.6 m -115.94 97.92 6.36 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.135 -0.978 . . . . 0.0 109.417 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 19' ' ' THR . 2.0 mttt -43.87 120.12 1.94 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 30' ' ' TRP . 38.7 t -71.81 127.34 33.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 110.721 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.417 ' HB2' HG22 ' A' ' 32' ' ' VAL . 6.1 mm-40 -109.28 -21.56 12.49 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.639 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.0 OUTLIER -102.71 167.67 9.75 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 23' ' ' TYR . 1.3 m -170.71 108.72 0.32 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.88 -167.11 2.71 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.562 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.0 -6.21 12.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.102 -0.999 . . . . 0.0 108.968 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.619 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.69 8.27 32.47 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.33 -0.856 . . . . 0.0 109.159 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.01 -128.87 9.71 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.513 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 47.2 mt-30 -127.85 150.65 49.75 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.632 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -128.28 178.55 6.17 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.839 -1.163 . . . . 0.0 109.923 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.456 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -135.84 151.04 20.54 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.659 ' CG2' ' CZ3' ' A' ' 37' ' ' TRP . 37.9 t -105.48 133.73 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.945 -1.326 . . . . 0.0 109.148 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 68.8 mt-30 -154.23 135.38 13.96 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.453 -0.78 . . . . 0.0 109.577 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.446 ' HB3' ' HG2' ' A' ' 36' ' ' GLN . 3.9 t30 63.15 12.49 6.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.422 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.79 28.68 58.63 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 36' ' ' GLN . 3.0 pt20 -135.69 142.74 45.14 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -1.159 . . . . 0.0 109.726 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.659 ' CZ3' ' CG2' ' A' ' 32' ' ' VAL . 1.1 m95 -76.43 134.38 39.6 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.852 0.834 . . . . 0.0 111.989 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 29.6 p -129.48 148.5 51.39 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.0 122.41 6.27 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.372 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.519 ' CG1' ' SG ' ' A' ' 13' ' ' CYS . 9.6 mt -89.87 120.24 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -1.039 . . . . 0.0 108.837 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 39.3 t0 . . . . . 0 C--N 1.299 -1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 109.639 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.638 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 8.1 p-90 -74.66 -19.41 60.29 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.924 -1.11 . . . . 0.0 109.848 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.2 -28.27 66.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 109.502 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -49.52 -35.56 20.5 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 109.932 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 t -48.76 -45.82 40.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 109.786 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.415 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 6.8 mt-30 -84.86 -25.4 28.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.983 . . . . 0.0 109.656 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.21 45.35 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.434 ' CD2' ' HZ3' ' A' ' 30' ' ' TRP . 53.3 m-85 -119.94 160.18 23.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -1.174 . . . . 0.0 108.922 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.446 ' ND2' ' N ' ' A' ' 11' ' ' ASN . 2.2 m120 -75.44 -151.39 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.086 -1.009 . . . . 0.0 111.064 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.477 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 35.2 m -141.87 136.24 30.34 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.525 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 9.2 m -75.57 133.78 40.87 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.058 -1.026 . . . . 0.0 110.232 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 15' ' ' ASN . 2.5 m-80 -71.21 133.85 46.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' ASN . 59.2 m-80 46.61 84.84 0.19 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.087 -1.008 . . . . 0.0 108.396 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.444 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 34.3 Cg_endo -75.94 -18.26 16.9 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.516 2.144 . . . . 0.0 110.875 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.7 m -74.59 0.46 14.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 109.798 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.85 22.33 1.77 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.019 -1.05 . . . . 0.0 109.831 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.454 ' O ' HG21 ' A' ' 19' ' ' THR . 2.8 m -107.72 98.52 8.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.151 -0.968 . . . . 0.0 109.262 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 19' ' ' THR . 8.8 mttp -43.56 118.58 1.41 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.355 -0.84 . . . . 0.0 109.128 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 30' ' ' TRP . 40.5 t -71.72 125.56 30.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.461 -0.775 . . . . 0.0 110.663 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.411 ' HB2' HG22 ' A' ' 32' ' ' VAL . 2.7 mm-40 -108.55 -21.61 12.64 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.638 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 1.0 OUTLIER -102.5 167.82 9.69 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 23' ' ' TYR . 1.1 m -170.84 109.36 0.33 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.451 ' OD2' ' CE2' ' A' ' 23' ' ' TYR . 3.3 m-20 -147.85 -167.28 2.75 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.638 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.45 -6.12 13.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.059 -1.026 . . . . 0.0 108.902 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.638 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.26 6.75 38.86 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.329 -0.857 . . . . 0.0 109.18 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.04 -129.55 9.93 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.508 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 54.1 mt-30 -127.49 149.58 50.06 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.638 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -127.62 179.16 5.66 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.992 -1.068 . . . . 0.0 109.819 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.55 153.38 21.6 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.653 ' CG2' ' CZ3' ' A' ' 37' ' ' TRP . 41.0 t -105.4 140.65 22.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.875 -1.368 . . . . 0.0 109.107 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.498 ' N ' HG11 ' A' ' 32' ' ' VAL . 2.6 mp0 -160.03 132.16 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 109.503 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 15.0 m-20 63.3 17.61 10.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.318 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.25 27.73 69.42 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.496 ' CG ' ' O ' ' A' ' 33' ' ' GLN . 1.2 pt20 -134.33 142.36 47.22 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.244 -1.15 . . . . 0.0 109.711 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.653 ' CZ3' ' CG2' ' A' ' 32' ' ' VAL . 1.3 m95 -76.65 136.67 39.17 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.91 0.862 . . . . 0.0 112.025 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 29.9 p -130.64 150.6 51.76 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.74 121.76 6.39 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.628 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.525 ' CG1' ' SG ' ' A' ' 13' ' ' CYS . 10.8 mt -89.06 121.48 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.411 -1.052 . . . . 0.0 108.874 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.527 ' OD1' ' CD1' ' A' ' 4' ' ' TRP . 7.9 t0 . . . . . 0 C--N 1.3 -1.558 0 O-C-N 121.357 -0.839 . . . . 0.0 109.933 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.319 0.581 . . . . 0.0 109.713 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.635 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 5.9 p-90 -77.33 -21.95 52.64 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.207 -0.933 . . . . 0.0 109.568 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.427 ' N ' ' CE3' ' A' ' 4' ' ' TRP . . . -63.65 -24.37 67.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.48 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -51.1 -31.69 20.06 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.249 -0.907 . . . . 0.0 110.002 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.34 -44.39 54.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 109.735 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 6.7 mt-30 -89.58 -25.08 21.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.09 45.6 0.86 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 8' ' ' GLN . 44.8 m-85 -115.45 163.11 16.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -1.192 . . . . 0.0 108.864 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -75.23 -150.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.068 -1.02 . . . . 0.0 110.904 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.464 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 9.3 m -147.44 131.5 17.27 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.522 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 5.0 m -71.6 137.03 47.66 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.096 -1.003 . . . . 0.0 110.306 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -80.61 129.75 34.7 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.63 90.03 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.978 . . . . 0.0 108.854 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 35.3 Cg_endo -77.41 -26.58 7.18 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.666 2.244 . . . . 0.0 111.007 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.5 p -72.58 0.34 10.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.266 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.5 p -142.08 28.61 1.7 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.901 -1.124 . . . . 0.0 110.124 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.465 ' O ' HG21 ' A' ' 19' ' ' THR . 3.0 m -120.27 96.91 5.34 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.002 -1.061 . . . . 0.0 109.448 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.44 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 28.8 mtmt -46.23 119.46 2.34 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.29 -0.881 . . . . 0.0 109.13 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 30' ' ' TRP . 40.3 t -70.08 126.66 30.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.503 -0.748 . . . . 0.0 110.449 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.44 ' OE2' ' O ' ' A' ' 20' ' ' LYS . 6.9 mm-40 -109.02 -21.75 12.48 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.641 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.98 167.51 9.79 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 23' ' ' TYR . 1.1 m -170.81 109.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.572 ' OD1' ' CE2' ' A' ' 23' ' ' TYR . 3.5 m-20 -148.6 -165.18 2.2 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.773 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.33 -5.47 14.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.21 -0.931 . . . . 0.0 108.847 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.635 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.4 m -90.86 7.45 39.88 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.342 -0.849 . . . . 0.0 109.169 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.25 -127.81 9.36 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.52 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 55.6 mt-30 -129.22 150.06 50.76 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.634 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -128.15 179.27 5.69 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.952 -1.092 . . . . 0.0 109.826 -179.151 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.22 153.36 21.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.66 ' CG2' ' CZ3' ' A' ' 37' ' ' TRP . 37.1 t -107.85 134.54 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.983 -1.304 . . . . 0.0 109.208 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 73.1 mt-30 -159.72 144.6 15.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.548 -0.72 . . . . 0.0 109.582 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.526 ' CB ' ' OE1' ' A' ' 36' ' ' GLN . 0.9 OUTLIER 59.42 14.99 4.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.76 34.61 62.52 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.526 ' OE1' ' CB ' ' A' ' 34' ' ' ASN . 0.3 OUTLIER -145.94 148.55 32.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.153 -1.204 . . . . 0.0 109.722 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.66 ' CZ3' ' CG2' ' A' ' 32' ' ' VAL . 1.3 m95 -78.27 136.75 37.82 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.911 0.862 . . . . 0.0 112.041 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.491 ' HB2' ' N ' ' A' ' 13' ' ' CYS . 28.3 p -131.39 146.24 52.18 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.59 123.02 6.31 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.522 ' CG1' ' SG ' ' A' ' 13' ' ' CYS . 6.2 mt -89.28 118.07 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.362 -1.081 . . . . 0.0 109.035 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 24.7 t70 . . . . . 0 C--N 1.3 -1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.368 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.296 0.569 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.632 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 6.4 p-90 -77.17 -25.57 52.04 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 109.726 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.463 ' N ' ' CE3' ' A' ' 4' ' ' TRP . . . -60.36 -24.13 64.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.405 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.77 -32.56 52.85 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.103 -0.998 . . . . 0.0 109.734 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.3 t -45.63 -41.32 10.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.524 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -94.04 -33.39 13.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 109.669 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.74 28.66 1.25 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.703 -1.236 . . . . 0.0 110.248 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.432 ' CG ' ' HZ3' ' A' ' 30' ' ' TRP . 46.7 m-85 -95.56 166.99 11.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.084 -1.245 . . . . 0.0 108.946 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.5 m120 -79.47 -151.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.001 -1.062 . . . . 0.0 110.956 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.49 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 30.6 m -145.28 133.99 22.24 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.519 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 6.6 m -73.02 138.46 45.98 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.129 -0.982 . . . . 0.0 110.425 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.2 m-20 -77.9 134.54 37.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 48.41 80.45 0.3 Allowed Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.963 -1.086 . . . . 0.0 108.429 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.4 -15.45 17.75 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.695 2.264 . . . . 0.0 110.861 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -70.83 -3.14 17.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.128 -0.983 . . . . 0.0 109.937 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 93.9 p -146.81 29.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 0.0 109.925 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.425 ' O ' HG21 ' A' ' 19' ' ' THR . 3.4 m -106.78 98.78 8.4 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.145 -0.972 . . . . 0.0 109.325 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 19' ' ' THR . 14.7 mttt -43.52 119.0 1.5 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.816 . . . . 0.0 109.179 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 30' ' ' TRP . 42.8 t -73.29 124.29 30.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 110.834 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.93 -21.76 12.7 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.637 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.16 167.45 10.0 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 23' ' ' TYR . 1.3 m -170.78 109.03 0.32 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.43 -167.53 2.81 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.396 -0.921 . . . . 0.0 109.685 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.36 -6.07 12.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.011 . . . . 0.0 108.87 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.632 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.69 7.61 35.81 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.326 -0.859 . . . . 0.0 109.076 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.3 -129.73 9.99 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.509 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 61.2 mt-30 -127.04 150.02 49.64 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.633 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -128.35 178.54 6.2 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.907 -1.121 . . . . 0.0 109.806 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.01 154.66 22.0 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.66 ' CG2' ' CZ3' ' A' ' 37' ' ' TRP . 41.6 t -106.97 139.67 27.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.841 -1.387 . . . . 0.0 109.068 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.489 ' N ' HG11 ' A' ' 32' ' ' VAL . 1.2 mp0 -162.24 139.15 8.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.488 -0.757 . . . . 0.0 109.536 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.95 13.03 5.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.46 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.05 30.4 59.17 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 33' ' ' GLN . 4.5 pt20 -141.16 146.32 36.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -1.203 . . . . 0.0 109.63 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.66 ' CZ3' ' CG2' ' A' ' 32' ' ' VAL . 1.4 m95 -76.53 137.28 39.49 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.843 0.83 . . . . 0.0 112.024 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.49 ' HB2' ' C ' ' A' ' 12' ' ' CYS . 29.7 p -131.17 147.7 52.63 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.13 123.33 6.52 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.519 ' CG1' ' SG ' ' A' ' 13' ' ' CYS . 6.2 mt -90.51 117.7 34.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.302 -1.117 . . . . 0.0 108.955 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t0 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 -179.648 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.272 0.558 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.631 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 7.1 p-90 -76.76 -26.38 54.48 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.808 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.464 ' N ' ' CE3' ' A' ' 4' ' ' TRP . . . -64.09 -22.87 67.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.529 ' CG ' ' N ' ' A' ' 7' ' ' SER . 6.6 pt20 -53.75 -44.8 70.26 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.529 ' N ' ' CG ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -46.01 -35.35 4.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.014 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -90.75 -29.97 17.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.056 -1.027 . . . . 0.0 109.922 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.25 39.33 0.95 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.434 ' CD2' ' HZ3' ' A' ' 30' ' ' TRP . 49.9 m-85 -116.34 161.09 19.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -1.199 . . . . 0.0 108.923 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -73.75 -150.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.09 -1.006 . . . . 0.0 110.947 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.458 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 24.7 m -147.08 132.5 18.61 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.526 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 5.0 m -73.67 133.94 43.51 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.191 -0.943 . . . . 0.0 110.382 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -76.74 132.02 39.06 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.7 m120 55.54 91.05 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.055 -1.028 . . . . 0.0 108.821 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 35.1 Cg_endo -77.25 -28.72 5.5 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.705 2.27 . . . . 0.0 110.877 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.13 -2.71 13.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.137 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.8 34.46 1.98 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 0.0 110.095 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 19' ' ' THR . 2.1 m -125.51 96.63 4.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.981 -1.075 . . . . 0.0 109.36 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 19' ' ' THR . 9.1 mttm -44.61 117.74 1.38 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.396 -0.815 . . . . 0.0 109.196 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 23' ' ' TYR . 38.9 t -73.29 126.94 34.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.454 -0.779 . . . . 0.0 110.712 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.459 ' OE1' ' HB ' ' A' ' 32' ' ' VAL . 0.4 OUTLIER -108.85 -20.86 12.91 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 177.681 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.642 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.99 166.64 10.33 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -170.87 109.02 0.32 Allowed 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 24' ' ' THR . 26.7 m-20 -147.32 -167.31 2.75 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.591 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.29 -6.13 12.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 108.814 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.631 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.4 m -88.2 6.94 34.27 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.352 -0.842 . . . . 0.0 109.145 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.83 -126.08 8.8 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.522 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 9.7 mt-30 -128.99 152.62 48.4 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.635 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -131.76 174.29 10.29 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.907 -1.121 . . . . 0.0 109.751 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -132.71 153.34 20.62 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.664 ' CG2' ' CZ3' ' A' ' 37' ' ' TRP . 25.1 t -107.85 131.71 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.995 -1.297 . . . . 0.0 109.101 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.51 ' O ' ' CG ' ' A' ' 36' ' ' GLN . 44.0 mt-30 -150.33 132.8 15.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 109.564 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.445 ' HB3' ' HG2' ' A' ' 36' ' ' GLN . 13.1 t-20 63.02 16.01 8.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -0.868 . . . . 0.0 109.413 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.39 28.16 64.32 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.51 ' CG ' ' O ' ' A' ' 33' ' ' GLN . 0.8 OUTLIER -132.49 142.5 49.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.151 -1.205 . . . . 0.0 109.541 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.664 ' CZ3' ' CG2' ' A' ' 32' ' ' VAL . 1.3 m95 -78.05 135.08 37.68 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.856 0.836 . . . . 0.0 111.976 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 28.6 p -130.35 147.71 52.09 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.02 122.17 6.32 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.526 ' CG1' ' SG ' ' A' ' 13' ' ' CYS . 8.0 mt -88.3 120.33 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.401 -1.058 . . . . 0.0 108.967 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 26.7 t70 . . . . . 0 C--N 1.299 -1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 109.1 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.457 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -168.33 -152.16 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -43.83 103.38 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.158 -0.964 . . . . 0.0 109.671 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.619 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 6.2 p-90 -76.72 -31.0 56.88 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.192 -0.943 . . . . 0.0 109.685 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.555 ' N ' ' CE3' ' A' ' 4' ' ' TRP . . . -57.99 -23.06 52.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 109.309 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.528 ' CG ' ' N ' ' A' ' 7' ' ' SER . 7.6 pt20 -54.14 -45.15 71.91 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.254 -0.904 . . . . 0.0 110.174 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.528 ' N ' ' CG ' ' A' ' 6' ' ' GLN . 28.0 t -43.36 -35.89 1.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 0.0 109.777 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -89.98 -35.56 15.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.862 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.21 20.65 2.68 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.309 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.445 ' CD2' ' HZ3' ' A' ' 30' ' ' TRP . 39.9 m-85 -94.11 169.67 10.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.937 -1.331 . . . . 0.0 109.081 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 0.9 OUTLIER -81.44 -151.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.051 -1.031 . . . . 0.0 110.845 -178.54 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.473 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 33.3 m -145.39 134.92 23.25 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.577 ' O ' ' CE2' ' A' ' 44' ' ' TYR . 5.3 m -75.21 131.85 40.7 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.152 -0.968 . . . . 0.0 110.434 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -70.84 130.42 41.62 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 49.88 84.49 0.2 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.083 -1.011 . . . . 0.0 108.704 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 34.2 Cg_endo -76.99 -16.4 15.98 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.736 2.291 . . . . 0.0 110.831 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -1.55 15.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.925 . . . . 0.0 109.964 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 m -143.79 29.38 1.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.02 -1.05 . . . . 0.0 109.99 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 19' ' ' THR . 2.6 m -115.94 97.92 6.36 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.135 -0.978 . . . . 0.0 109.417 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 19' ' ' THR . 2.0 mttt -43.87 120.12 1.94 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 30' ' ' TRP . 38.7 t -71.81 127.34 33.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 110.721 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.417 ' HB2' HG22 ' A' ' 32' ' ' VAL . 6.1 mm-40 -109.28 -21.56 12.49 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.639 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.0 OUTLIER -102.71 167.67 9.75 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 23' ' ' TYR . 1.3 m -170.71 108.72 0.32 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.88 -167.11 2.71 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.562 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.0 -6.21 12.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.102 -0.999 . . . . 0.0 108.968 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.619 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.69 8.27 32.47 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.33 -0.856 . . . . 0.0 109.159 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.01 -128.87 9.71 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.513 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 47.2 mt-30 -127.85 150.65 49.75 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.632 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -128.28 178.55 6.17 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.839 -1.163 . . . . 0.0 109.923 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.456 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -135.84 151.04 20.54 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.659 ' CG2' ' CZ3' ' A' ' 37' ' ' TRP . 37.9 t -105.48 133.73 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.945 -1.326 . . . . 0.0 109.148 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 68.8 mt-30 -154.23 135.38 13.96 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.453 -0.78 . . . . 0.0 109.577 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.446 ' HB3' ' HG2' ' A' ' 36' ' ' GLN . 3.9 t30 63.15 12.49 6.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.422 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.79 28.68 58.63 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 36' ' ' GLN . 3.0 pt20 -135.69 142.74 45.14 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -1.159 . . . . 0.0 109.726 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.659 ' CZ3' ' CG2' ' A' ' 32' ' ' VAL . 1.1 m95 -76.43 134.38 39.6 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.852 0.834 . . . . 0.0 111.989 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 29.6 p -129.48 148.5 51.39 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.0 122.41 6.27 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.372 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.519 ' CG1' ' SG ' ' A' ' 13' ' ' CYS . 9.6 mt -89.87 120.24 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -1.039 . . . . 0.0 108.837 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.468 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 39.3 t0 -142.61 146.62 34.73 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 109.639 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -76.96 -37.28 55.52 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.213 -0.93 . . . . 0.0 109.583 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.0 m -74.85 -1.18 21.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.228 -0.92 . . . . 0.0 109.414 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.577 ' CE2' ' O ' ' A' ' 13' ' ' CYS . 7.1 t80 -73.38 99.57 2.98 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.235 -0.916 . . . . 0.0 109.122 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.94 -34.65 0.54 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.296 -1.12 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 4' ' ' TRP . 82.9 p -179.06 -153.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.465 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m -50.58 90.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.628 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.638 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 8.1 p-90 -74.66 -19.41 60.29 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.924 -1.11 . . . . 0.0 109.848 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.2 -28.27 66.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 109.502 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -49.52 -35.56 20.5 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 109.932 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 t -48.76 -45.82 40.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 109.786 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.415 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 6.8 mt-30 -84.86 -25.4 28.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.983 . . . . 0.0 109.656 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.21 45.35 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.434 ' CD2' ' HZ3' ' A' ' 30' ' ' TRP . 53.3 m-85 -119.94 160.18 23.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -1.174 . . . . 0.0 108.922 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.446 ' ND2' ' N ' ' A' ' 11' ' ' ASN . 2.2 m120 -75.44 -151.39 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.086 -1.009 . . . . 0.0 111.064 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.477 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 35.2 m -141.87 136.24 30.34 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.58 ' O ' ' CE2' ' A' ' 44' ' ' TYR . 9.2 m -75.57 133.78 40.87 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.058 -1.026 . . . . 0.0 110.232 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 15' ' ' ASN . 2.5 m-80 -71.21 133.85 46.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' ASN . 59.2 m-80 46.61 84.84 0.19 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.087 -1.008 . . . . 0.0 108.396 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.444 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 34.3 Cg_endo -75.94 -18.26 16.9 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.516 2.144 . . . . 0.0 110.875 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.7 m -74.59 0.46 14.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 109.798 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.85 22.33 1.77 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.019 -1.05 . . . . 0.0 109.831 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.454 ' O ' HG21 ' A' ' 19' ' ' THR . 2.8 m -107.72 98.52 8.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.151 -0.968 . . . . 0.0 109.262 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 19' ' ' THR . 8.8 mttp -43.56 118.58 1.41 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.355 -0.84 . . . . 0.0 109.128 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 30' ' ' TRP . 40.5 t -71.72 125.56 30.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.461 -0.775 . . . . 0.0 110.663 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.411 ' HB2' HG22 ' A' ' 32' ' ' VAL . 2.7 mm-40 -108.55 -21.61 12.64 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.638 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 1.0 OUTLIER -102.5 167.82 9.69 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 23' ' ' TYR . 1.1 m -170.84 109.36 0.33 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.451 ' OD2' ' CE2' ' A' ' 23' ' ' TYR . 3.3 m-20 -147.85 -167.28 2.75 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.638 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.45 -6.12 13.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.059 -1.026 . . . . 0.0 108.902 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.638 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.26 6.75 38.86 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.329 -0.857 . . . . 0.0 109.18 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.04 -129.55 9.93 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.508 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 54.1 mt-30 -127.49 149.58 50.06 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.638 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -127.62 179.16 5.66 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.992 -1.068 . . . . 0.0 109.819 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.55 153.38 21.6 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.653 ' CG2' ' CZ3' ' A' ' 37' ' ' TRP . 41.0 t -105.4 140.65 22.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.875 -1.368 . . . . 0.0 109.107 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.498 ' N ' HG11 ' A' ' 32' ' ' VAL . 2.6 mp0 -160.03 132.16 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 109.503 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 15.0 m-20 63.3 17.61 10.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.318 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.25 27.73 69.42 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.496 ' CG ' ' O ' ' A' ' 33' ' ' GLN . 1.2 pt20 -134.33 142.36 47.22 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.244 -1.15 . . . . 0.0 109.711 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.653 ' CZ3' ' CG2' ' A' ' 32' ' ' VAL . 1.3 m95 -76.65 136.67 39.17 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.91 0.862 . . . . 0.0 112.025 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 29.9 p -130.64 150.6 51.76 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.74 121.76 6.39 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.628 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.525 ' CG1' ' SG ' ' A' ' 13' ' ' CYS . 10.8 mt -89.06 121.48 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.411 -1.052 . . . . 0.0 108.874 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.527 ' OD1' ' CD1' ' A' ' 4' ' ' TRP . 7.9 t0 -140.39 147.19 39.39 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.357 -0.839 . . . . 0.0 109.933 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -76.6 -39.98 50.92 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.324 -0.86 . . . . 0.0 109.505 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.3 m -81.94 6.8 14.8 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.281 -0.887 . . . . 0.0 109.224 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 13' ' ' CYS . 9.6 t80 -74.54 121.54 21.7 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.292 -0.88 . . . . 0.0 109.165 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' A' ' 46' ' ' GLN . . . 109.51 -7.53 32.12 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 13.9 pm0 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.51 -0.994 . . . . 0.0 109.976 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.57 -164.72 0.18 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 109.452 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -48.87 99.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 109.713 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.635 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 5.9 p-90 -77.33 -21.95 52.64 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.207 -0.933 . . . . 0.0 109.568 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.427 ' N ' ' CE3' ' A' ' 4' ' ' TRP . . . -63.65 -24.37 67.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.48 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -51.1 -31.69 20.06 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.249 -0.907 . . . . 0.0 110.002 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.34 -44.39 54.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 109.735 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 6.7 mt-30 -89.58 -25.08 21.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.09 45.6 0.86 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 8' ' ' GLN . 44.8 m-85 -115.45 163.11 16.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -1.192 . . . . 0.0 108.864 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -75.23 -150.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.068 -1.02 . . . . 0.0 110.904 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.464 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 9.3 m -147.44 131.5 17.27 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.573 ' O ' ' CE2' ' A' ' 44' ' ' TYR . 5.0 m -71.6 137.03 47.66 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.096 -1.003 . . . . 0.0 110.306 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -80.61 129.75 34.7 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.63 90.03 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.978 . . . . 0.0 108.854 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 35.3 Cg_endo -77.41 -26.58 7.18 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.666 2.244 . . . . 0.0 111.007 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.5 p -72.58 0.34 10.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.266 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.5 p -142.08 28.61 1.7 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.901 -1.124 . . . . 0.0 110.124 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.465 ' O ' HG21 ' A' ' 19' ' ' THR . 3.0 m -120.27 96.91 5.34 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.002 -1.061 . . . . 0.0 109.448 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.44 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 28.8 mtmt -46.23 119.46 2.34 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.29 -0.881 . . . . 0.0 109.13 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 30' ' ' TRP . 40.3 t -70.08 126.66 30.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.503 -0.748 . . . . 0.0 110.449 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.44 ' OE2' ' O ' ' A' ' 20' ' ' LYS . 6.9 mm-40 -109.02 -21.75 12.48 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.641 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.98 167.51 9.79 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 23' ' ' TYR . 1.1 m -170.81 109.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.572 ' OD1' ' CE2' ' A' ' 23' ' ' TYR . 3.5 m-20 -148.6 -165.18 2.2 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.773 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.33 -5.47 14.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.21 -0.931 . . . . 0.0 108.847 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.635 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.4 m -90.86 7.45 39.88 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.342 -0.849 . . . . 0.0 109.169 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.25 -127.81 9.36 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.52 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 55.6 mt-30 -129.22 150.06 50.76 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.634 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -128.15 179.27 5.69 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.952 -1.092 . . . . 0.0 109.826 -179.151 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.22 153.36 21.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.66 ' CG2' ' CZ3' ' A' ' 37' ' ' TRP . 37.1 t -107.85 134.54 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.983 -1.304 . . . . 0.0 109.208 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 73.1 mt-30 -159.72 144.6 15.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.548 -0.72 . . . . 0.0 109.582 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.526 ' CB ' ' OE1' ' A' ' 36' ' ' GLN . 0.9 OUTLIER 59.42 14.99 4.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.76 34.61 62.52 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.526 ' OE1' ' CB ' ' A' ' 34' ' ' ASN . 0.3 OUTLIER -145.94 148.55 32.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.153 -1.204 . . . . 0.0 109.722 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.66 ' CZ3' ' CG2' ' A' ' 32' ' ' VAL . 1.3 m95 -78.27 136.75 37.82 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.911 0.862 . . . . 0.0 112.041 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.491 ' HB2' ' N ' ' A' ' 13' ' ' CYS . 28.3 p -131.39 146.24 52.18 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.59 123.02 6.31 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.522 ' CG1' ' SG ' ' A' ' 13' ' ' CYS . 6.2 mt -89.28 118.07 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.362 -1.081 . . . . 0.0 109.035 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.471 ' HB3' ' CB ' ' A' ' 44' ' ' TYR . 24.7 t70 -128.81 137.98 51.81 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.368 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -72.94 -36.94 67.3 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.145 -0.972 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.39 -10.41 59.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.222 -0.924 . . . . 0.0 108.987 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.573 ' CE2' ' O ' ' A' ' 13' ' ' CYS . 10.9 t80 -75.93 136.82 40.07 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.377 -0.827 . . . . 0.0 109.158 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.45 -55.36 0.17 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.245 -1.15 . . . . 0.0 109.439 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.401 ' C ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.401 ' OG ' ' C ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -179.59 -163.85 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.56 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -43.38 102.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.798 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.632 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 6.4 p-90 -77.17 -25.57 52.04 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 109.726 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.463 ' N ' ' CE3' ' A' ' 4' ' ' TRP . . . -60.36 -24.13 64.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.405 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.77 -32.56 52.85 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.103 -0.998 . . . . 0.0 109.734 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.3 t -45.63 -41.32 10.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.524 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -94.04 -33.39 13.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 109.669 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.74 28.66 1.25 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.703 -1.236 . . . . 0.0 110.248 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.432 ' CG ' ' HZ3' ' A' ' 30' ' ' TRP . 46.7 m-85 -95.56 166.99 11.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.084 -1.245 . . . . 0.0 108.946 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.5 m120 -79.47 -151.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.001 -1.062 . . . . 0.0 110.956 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.49 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 30.6 m -145.28 133.99 22.24 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.582 ' O ' ' CE2' ' A' ' 44' ' ' TYR . 6.6 m -73.02 138.46 45.98 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.129 -0.982 . . . . 0.0 110.425 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.2 m-20 -77.9 134.54 37.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 48.41 80.45 0.3 Allowed Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.963 -1.086 . . . . 0.0 108.429 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.4 -15.45 17.75 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.695 2.264 . . . . 0.0 110.861 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -70.83 -3.14 17.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.128 -0.983 . . . . 0.0 109.937 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 93.9 p -146.81 29.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 0.0 109.925 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.425 ' O ' HG21 ' A' ' 19' ' ' THR . 3.4 m -106.78 98.78 8.4 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.145 -0.972 . . . . 0.0 109.325 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 19' ' ' THR . 14.7 mttt -43.52 119.0 1.5 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.816 . . . . 0.0 109.179 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 30' ' ' TRP . 42.8 t -73.29 124.29 30.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 110.834 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.93 -21.76 12.7 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.637 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.16 167.45 10.0 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 23' ' ' TYR . 1.3 m -170.78 109.03 0.32 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.43 -167.53 2.81 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.396 -0.921 . . . . 0.0 109.685 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.36 -6.07 12.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.011 . . . . 0.0 108.87 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.632 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.69 7.61 35.81 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.326 -0.859 . . . . 0.0 109.076 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.3 -129.73 9.99 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.509 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 61.2 mt-30 -127.04 150.02 49.64 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.633 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -128.35 178.54 6.2 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.907 -1.121 . . . . 0.0 109.806 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.01 154.66 22.0 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.66 ' CG2' ' CZ3' ' A' ' 37' ' ' TRP . 41.6 t -106.97 139.67 27.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.841 -1.387 . . . . 0.0 109.068 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.489 ' N ' HG11 ' A' ' 32' ' ' VAL . 1.2 mp0 -162.24 139.15 8.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.488 -0.757 . . . . 0.0 109.536 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.95 13.03 5.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.46 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.05 30.4 59.17 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 33' ' ' GLN . 4.5 pt20 -141.16 146.32 36.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -1.203 . . . . 0.0 109.63 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.66 ' CZ3' ' CG2' ' A' ' 32' ' ' VAL . 1.4 m95 -76.53 137.28 39.49 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.843 0.83 . . . . 0.0 112.024 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.49 ' HB2' ' C ' ' A' ' 12' ' ' CYS . 29.7 p -131.17 147.7 52.63 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.13 123.33 6.52 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.519 ' CG1' ' SG ' ' A' ' 13' ' ' CYS . 6.2 mt -90.51 117.7 34.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.302 -1.117 . . . . 0.0 108.955 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -137.88 148.04 45.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -78.04 -34.69 50.42 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.337 -0.852 . . . . 0.0 109.523 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 0.3 OUTLIER -75.91 -0.33 21.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.336 179.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.582 ' CE2' ' O ' ' A' ' 13' ' ' CYS . 22.3 t80 -80.0 150.91 30.27 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.318 -0.864 . . . . 0.0 109.154 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.01 56.31 17.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 43' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.265 -1.138 . . . . 0.0 109.502 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.524 ' CB ' ' OD2' ' A' ' 41' ' ' ASP . 66.8 m -83.4 9.1 11.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.553 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.12 106.52 1.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.554 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.631 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 7.1 p-90 -76.76 -26.38 54.48 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.808 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.464 ' N ' ' CE3' ' A' ' 4' ' ' TRP . . . -64.09 -22.87 67.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.529 ' CG ' ' N ' ' A' ' 7' ' ' SER . 6.6 pt20 -53.75 -44.8 70.26 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.529 ' N ' ' CG ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -46.01 -35.35 4.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.014 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -90.75 -29.97 17.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.056 -1.027 . . . . 0.0 109.922 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.25 39.33 0.95 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.434 ' CD2' ' HZ3' ' A' ' 30' ' ' TRP . 49.9 m-85 -116.34 161.09 19.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -1.199 . . . . 0.0 108.923 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -73.75 -150.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.09 -1.006 . . . . 0.0 110.947 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.458 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 24.7 m -147.08 132.5 18.61 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.579 ' O ' ' CE2' ' A' ' 44' ' ' TYR . 5.0 m -73.67 133.94 43.51 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.191 -0.943 . . . . 0.0 110.382 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -76.74 132.02 39.06 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.7 m120 55.54 91.05 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.055 -1.028 . . . . 0.0 108.821 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 35.1 Cg_endo -77.25 -28.72 5.5 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.705 2.27 . . . . 0.0 110.877 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.13 -2.71 13.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.137 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.8 34.46 1.98 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 0.0 110.095 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 19' ' ' THR . 2.1 m -125.51 96.63 4.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.981 -1.075 . . . . 0.0 109.36 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 19' ' ' THR . 9.1 mttm -44.61 117.74 1.38 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.396 -0.815 . . . . 0.0 109.196 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 23' ' ' TYR . 38.9 t -73.29 126.94 34.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.454 -0.779 . . . . 0.0 110.712 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.459 ' OE1' ' HB ' ' A' ' 32' ' ' VAL . 0.4 OUTLIER -108.85 -20.86 12.91 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 177.681 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.642 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.99 166.64 10.33 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -170.87 109.02 0.32 Allowed 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 24' ' ' THR . 26.7 m-20 -147.32 -167.31 2.75 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.591 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.29 -6.13 12.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 108.814 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.631 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.4 m -88.2 6.94 34.27 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.352 -0.842 . . . . 0.0 109.145 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.83 -126.08 8.8 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.522 ' O ' ' HB ' ' A' ' 40' ' ' ILE . 9.7 mt-30 -128.99 152.62 48.4 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.635 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -131.76 174.29 10.29 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.907 -1.121 . . . . 0.0 109.751 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -132.71 153.34 20.62 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.664 ' CG2' ' CZ3' ' A' ' 37' ' ' TRP . 25.1 t -107.85 131.71 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.995 -1.297 . . . . 0.0 109.101 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.51 ' O ' ' CG ' ' A' ' 36' ' ' GLN . 44.0 mt-30 -150.33 132.8 15.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 109.564 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.445 ' HB3' ' HG2' ' A' ' 36' ' ' GLN . 13.1 t-20 63.02 16.01 8.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -0.868 . . . . 0.0 109.413 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.39 28.16 64.32 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.51 ' CG ' ' O ' ' A' ' 33' ' ' GLN . 0.8 OUTLIER -132.49 142.5 49.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.151 -1.205 . . . . 0.0 109.541 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.664 ' CZ3' ' CG2' ' A' ' 32' ' ' VAL . 1.3 m95 -78.05 135.08 37.68 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.856 0.836 . . . . 0.0 111.976 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 28.6 p -130.35 147.71 52.09 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.02 122.17 6.32 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.526 ' CG1' ' SG ' ' A' ' 13' ' ' CYS . 8.0 mt -88.3 120.33 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.401 -1.058 . . . . 0.0 108.967 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' HB3' ' CB ' ' A' ' 44' ' ' TYR . 26.7 t70 -129.6 134.84 47.93 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 109.1 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -69.61 -36.79 76.49 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.191 -0.943 . . . . 0.0 109.485 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.475 ' HB3' ' CB ' ' A' ' 2' ' ' SER . 47.9 t -76.7 -9.64 58.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.927 . . . . 0.0 109.062 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.579 ' CE2' ' O ' ' A' ' 13' ' ' CYS . 8.4 t80 -76.04 115.7 16.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.366 -0.834 . . . . 0.0 109.17 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.59 -11.43 61.61 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.19 -1.182 . . . . 0.0 109.423 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.341 0.591 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.619 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 6.2 p-90 -76.72 -31.0 56.88 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.192 -0.943 . . . . 0.0 109.685 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.731 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -57.99 -23.06 52.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 109.309 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.528 ' CG ' ' N ' ' A' ' 7' ' ' SER . 7.6 pt20 -54.14 -45.15 71.91 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.254 -0.904 . . . . 0.0 110.174 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.528 ' N ' ' CG ' ' A' ' 6' ' ' GLN . 28.0 t -43.36 -35.89 1.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 0.0 109.777 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.493 HE21 ' HB3' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -89.98 -35.56 15.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.862 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.21 20.65 2.68 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.309 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.731 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 39.9 m-85 -94.11 169.67 10.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.937 -1.331 . . . . 0.0 109.081 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 0.9 OUTLIER -81.44 -151.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.051 -1.031 . . . . 0.0 110.845 -178.54 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.489 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 33.3 m -145.39 134.92 23.25 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.519 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 5.3 m -75.21 131.85 40.7 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.152 -0.968 . . . . 0.0 110.434 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -70.84 130.42 41.62 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 49.88 84.49 0.2 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.083 -1.011 . . . . 0.0 108.704 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.631 ' CB ' HG23 ' A' ' 40' ' ' ILE . 34.2 Cg_endo -76.99 -16.4 15.98 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.736 2.291 . . . . 0.0 110.831 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -1.55 15.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.925 . . . . 0.0 109.964 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 m -143.79 29.38 1.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.02 -1.05 . . . . 0.0 109.99 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.542 HG22 HD11 ' A' ' 40' ' ' ILE . 2.6 m -115.94 97.92 6.36 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.135 -0.978 . . . . 0.0 109.417 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 19' ' ' THR . 2.0 mttt -43.87 120.12 1.94 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.905 HG22 HD12 ' A' ' 40' ' ' ILE . 38.7 t -71.81 127.34 33.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 110.721 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.416 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 6.1 mm-40 -109.28 -21.56 12.49 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.657 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.0 OUTLIER -102.71 167.67 9.75 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.61 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.3 m -170.71 108.72 0.32 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.88 -167.11 2.71 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.562 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.0 -6.21 12.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.102 -0.999 . . . . 0.0 108.968 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.619 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.69 8.27 32.47 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.33 -0.856 . . . . 0.0 109.159 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.01 -128.87 9.71 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.61 ' HG2' HG23 ' A' ' 24' ' ' THR . 47.2 mt-30 -127.85 150.65 49.75 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.649 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -128.28 178.55 6.17 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.839 -1.163 . . . . 0.0 109.923 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.456 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -135.84 151.04 20.54 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.864 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 37.9 t -105.48 133.73 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.945 -1.326 . . . . 0.0 109.148 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 68.8 mt-30 -154.23 135.38 13.96 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.453 -0.78 . . . . 0.0 109.577 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.47 ' HB3' ' HG2' ' A' ' 36' ' ' GLN . 3.9 t30 63.15 12.49 6.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.422 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.79 28.68 58.63 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.47 ' HG2' ' HB3' ' A' ' 34' ' ' ASN . 3.0 pt20 -135.69 142.74 45.14 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -1.159 . . . . 0.0 109.726 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.864 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.1 m95 -76.43 134.38 39.6 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.852 0.834 . . . . 0.0 111.989 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.489 ' HB2' ' C ' ' A' ' 12' ' ' CYS . 29.6 p -129.48 148.5 51.39 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.0 122.41 6.27 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.372 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.905 HD12 HG22 ' A' ' 21' ' ' VAL . 9.6 mt -89.87 120.24 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -1.039 . . . . 0.0 108.837 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.5 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 39.3 t0 . . . . . 0 C--N 1.299 -1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 109.639 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.638 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 8.1 p-90 -74.66 -19.41 60.29 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.924 -1.11 . . . . 0.0 109.848 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.819 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -69.2 -28.27 66.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 109.502 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -49.52 -35.56 20.5 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 109.932 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 t -48.76 -45.82 40.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 109.786 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.431 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 6.8 mt-30 -84.86 -25.4 28.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.983 . . . . 0.0 109.656 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.21 45.35 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.819 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 53.3 m-85 -119.94 160.18 23.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -1.174 . . . . 0.0 108.922 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -75.44 -151.39 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.086 -1.009 . . . . 0.0 111.064 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.494 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 35.2 m -141.87 136.24 30.34 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.525 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 9.2 m -75.57 133.78 40.87 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.058 -1.026 . . . . 0.0 110.232 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 15' ' ' ASN . 2.5 m-80 -71.21 133.85 46.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' ASN . 59.2 m-80 46.61 84.84 0.19 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.087 -1.008 . . . . 0.0 108.396 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.616 ' CB ' HG23 ' A' ' 40' ' ' ILE . 34.3 Cg_endo -75.94 -18.26 16.9 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.516 2.144 . . . . 0.0 110.875 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.7 m -74.59 0.46 14.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 109.798 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.85 22.33 1.77 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.019 -1.05 . . . . 0.0 109.831 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.587 HG22 HD11 ' A' ' 40' ' ' ILE . 2.8 m -107.72 98.52 8.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.151 -0.968 . . . . 0.0 109.262 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 19' ' ' THR . 8.8 mttp -43.56 118.58 1.41 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.355 -0.84 . . . . 0.0 109.128 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.923 HG22 HD12 ' A' ' 40' ' ' ILE . 40.5 t -71.72 125.56 30.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.461 -0.775 . . . . 0.0 110.663 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -108.55 -21.61 12.64 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.658 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 1.0 OUTLIER -102.5 167.82 9.69 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.443 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.656 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.1 m -170.84 109.36 0.33 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.451 ' OD2' ' CE2' ' A' ' 23' ' ' TYR . 3.3 m-20 -147.85 -167.28 2.75 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.638 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.45 -6.12 13.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.059 -1.026 . . . . 0.0 108.902 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.638 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.26 6.75 38.86 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.329 -0.857 . . . . 0.0 109.18 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.04 -129.55 9.93 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.656 ' HG2' HG23 ' A' ' 24' ' ' THR . 54.1 mt-30 -127.49 149.58 50.06 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.658 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -127.62 179.16 5.66 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.992 -1.068 . . . . 0.0 109.819 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.55 153.38 21.6 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.822 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 41.0 t -105.4 140.65 22.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.875 -1.368 . . . . 0.0 109.107 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.496 ' O ' ' CG ' ' A' ' 36' ' ' GLN . 2.6 mp0 -160.03 132.16 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 109.503 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 15.0 m-20 63.3 17.61 10.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.318 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.25 27.73 69.42 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.496 ' CG ' ' O ' ' A' ' 33' ' ' GLN . 3.5 pt20 -134.33 142.36 47.22 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.244 -1.15 . . . . 0.0 109.711 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.822 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.3 m95 -76.65 136.67 39.17 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.91 0.862 . . . . 0.0 112.025 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 29.9 p -130.64 150.6 51.76 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.74 121.76 6.39 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.628 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.923 HD12 HG22 ' A' ' 21' ' ' VAL . 10.8 mt -89.06 121.48 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.411 -1.052 . . . . 0.0 108.874 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.527 ' OD1' ' CD1' ' A' ' 4' ' ' TRP . 7.9 t0 . . . . . 0 C--N 1.3 -1.558 0 O-C-N 121.357 -0.839 . . . . 0.0 109.933 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.319 0.581 . . . . 0.0 109.713 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.635 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 5.9 p-90 -77.33 -21.95 52.64 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.207 -0.933 . . . . 0.0 109.568 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.834 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -63.65 -24.37 67.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.48 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -51.1 -31.69 20.06 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.249 -0.907 . . . . 0.0 110.002 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.34 -44.39 54.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 109.735 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.453 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 2.1 mt-30 -89.58 -25.08 21.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.09 45.6 0.86 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.834 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 44.8 m-85 -115.45 163.11 16.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -1.192 . . . . 0.0 108.864 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -75.23 -150.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.068 -1.02 . . . . 0.0 110.904 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.481 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 9.3 m -147.44 131.5 17.27 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.522 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 5.0 m -71.6 137.03 47.66 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.096 -1.003 . . . . 0.0 110.306 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -80.61 129.75 34.7 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m120 59.63 90.03 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.978 . . . . 0.0 108.854 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.487 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 35.3 Cg_endo -77.41 -26.58 7.18 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.666 2.244 . . . . 0.0 111.007 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.5 p -72.58 0.34 10.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.266 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.5 p -142.08 28.61 1.7 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.901 -1.124 . . . . 0.0 110.124 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.62 HG22 HD11 ' A' ' 40' ' ' ILE . 3.0 m -120.27 96.91 5.34 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.002 -1.061 . . . . 0.0 109.448 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.44 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 28.8 mtmt -46.23 119.46 2.34 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.29 -0.881 . . . . 0.0 109.13 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.806 HG22 HD12 ' A' ' 40' ' ' ILE . 40.3 t -70.08 126.66 30.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.503 -0.748 . . . . 0.0 110.449 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.44 ' OE2' ' O ' ' A' ' 20' ' ' LYS . 6.9 mm-40 -109.02 -21.75 12.48 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.661 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.98 167.51 9.79 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.637 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.1 m -170.81 109.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.572 ' OD1' ' CE2' ' A' ' 23' ' ' TYR . 3.5 m-20 -148.6 -165.18 2.2 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.773 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.33 -5.47 14.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.21 -0.931 . . . . 0.0 108.847 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.635 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.4 m -90.86 7.45 39.88 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.342 -0.849 . . . . 0.0 109.169 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.25 -127.81 9.36 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.637 ' HG2' HG23 ' A' ' 24' ' ' THR . 55.6 mt-30 -129.22 150.06 50.76 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.651 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -128.15 179.27 5.69 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.952 -1.092 . . . . 0.0 109.826 -179.151 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.22 153.36 21.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.863 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 37.1 t -107.85 134.54 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.983 -1.304 . . . . 0.0 109.208 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 73.1 mt-30 -159.72 144.6 15.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.548 -0.72 . . . . 0.0 109.582 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.526 ' CB ' ' OE1' ' A' ' 36' ' ' GLN . 0.9 OUTLIER 59.42 14.99 4.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.76 34.61 62.52 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.526 ' OE1' ' CB ' ' A' ' 34' ' ' ASN . 0.3 OUTLIER -145.94 148.55 32.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.153 -1.204 . . . . 0.0 109.722 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.863 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.3 m95 -78.27 136.75 37.82 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.911 0.862 . . . . 0.0 112.041 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.495 ' HB2' ' N ' ' A' ' 13' ' ' CYS . 28.3 p -131.39 146.24 52.18 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.59 123.02 6.31 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.806 HD12 HG22 ' A' ' 21' ' ' VAL . 6.2 mt -89.28 118.07 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.362 -1.081 . . . . 0.0 109.035 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 24.7 t70 . . . . . 0 C--N 1.3 -1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.368 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.296 0.569 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.632 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 6.4 p-90 -77.17 -25.57 52.04 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 109.726 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.823 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -60.36 -24.13 64.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.405 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.77 -32.56 52.85 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.103 -0.998 . . . . 0.0 109.734 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.3 t -45.63 -41.32 10.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.524 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -94.04 -33.39 13.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 109.669 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.74 28.66 1.25 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.703 -1.236 . . . . 0.0 110.248 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.823 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 46.7 m-85 -95.56 166.99 11.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.084 -1.245 . . . . 0.0 108.946 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.5 m120 -79.47 -151.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.001 -1.062 . . . . 0.0 110.956 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.504 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 30.6 m -145.28 133.99 22.24 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.519 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 6.6 m -73.02 138.46 45.98 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.129 -0.982 . . . . 0.0 110.425 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.2 m-20 -77.9 134.54 37.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 48.41 80.45 0.3 Allowed Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.963 -1.086 . . . . 0.0 108.429 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.421 ' CB ' HG23 ' A' ' 40' ' ' ILE . 34.9 Cg_endo -76.4 -15.45 17.75 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.695 2.264 . . . . 0.0 110.861 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -70.83 -3.14 17.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.128 -0.983 . . . . 0.0 109.937 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 93.9 p -146.81 29.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 0.0 109.925 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.659 HG22 HD11 ' A' ' 40' ' ' ILE . 3.4 m -106.78 98.78 8.4 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.145 -0.972 . . . . 0.0 109.325 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 19' ' ' THR . 14.7 mttt -43.52 119.0 1.5 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.816 . . . . 0.0 109.179 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.784 HG22 HD12 ' A' ' 40' ' ' ILE . 42.8 t -73.29 124.29 30.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 110.834 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.93 -21.76 12.7 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.655 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.16 167.45 10.0 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.586 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.3 m -170.78 109.03 0.32 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.43 -167.53 2.81 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.396 -0.921 . . . . 0.0 109.685 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.36 -6.07 12.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.011 . . . . 0.0 108.87 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.632 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.69 7.61 35.81 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.326 -0.859 . . . . 0.0 109.076 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.3 -129.73 9.99 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.586 ' HG2' HG23 ' A' ' 24' ' ' THR . 61.2 mt-30 -127.04 150.02 49.64 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.649 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -128.35 178.54 6.2 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.907 -1.121 . . . . 0.0 109.806 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.01 154.66 22.0 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.826 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 41.6 t -106.97 139.67 27.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.841 -1.387 . . . . 0.0 109.068 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 1.2 mp0 -162.24 139.15 8.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.488 -0.757 . . . . 0.0 109.536 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.95 13.03 5.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.46 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.05 30.4 59.17 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 33' ' ' GLN . 22.2 pt20 -141.16 146.32 36.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -1.203 . . . . 0.0 109.63 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.826 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.4 m95 -76.53 137.28 39.49 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.843 0.83 . . . . 0.0 112.024 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.504 ' HB2' ' C ' ' A' ' 12' ' ' CYS . 29.7 p -131.17 147.7 52.63 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.13 123.33 6.52 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.784 HD12 HG22 ' A' ' 21' ' ' VAL . 6.2 mt -90.51 117.7 34.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.302 -1.117 . . . . 0.0 108.955 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t0 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 -179.648 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.272 0.558 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.631 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 7.1 p-90 -76.76 -26.38 54.48 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.808 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.776 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -64.09 -22.87 67.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.529 ' CG ' ' N ' ' A' ' 7' ' ' SER . 6.6 pt20 -53.75 -44.8 70.26 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.529 ' N ' ' CG ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -46.01 -35.35 4.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.014 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -90.75 -29.97 17.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.056 -1.027 . . . . 0.0 109.922 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.25 39.33 0.95 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.776 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 49.9 m-85 -116.34 161.09 19.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -1.199 . . . . 0.0 108.923 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -73.75 -150.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.09 -1.006 . . . . 0.0 110.947 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.471 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 24.7 m -147.08 132.5 18.61 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.526 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 5.0 m -73.67 133.94 43.51 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.191 -0.943 . . . . 0.0 110.382 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -76.74 132.02 39.06 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.7 m120 55.54 91.05 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.055 -1.028 . . . . 0.0 108.821 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.555 ' HB3' HG23 ' A' ' 40' ' ' ILE . 35.1 Cg_endo -77.25 -28.72 5.5 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.705 2.27 . . . . 0.0 110.877 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.13 -2.71 13.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.137 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.8 34.46 1.98 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 0.0 110.095 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.558 HG22 HD11 ' A' ' 40' ' ' ILE . 2.1 m -125.51 96.63 4.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.981 -1.075 . . . . 0.0 109.36 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 19' ' ' THR . 9.1 mttm -44.61 117.74 1.38 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.396 -0.815 . . . . 0.0 109.196 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.94 HG22 HD12 ' A' ' 40' ' ' ILE . 38.9 t -73.29 126.94 34.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.454 -0.779 . . . . 0.0 110.712 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.466 ' OE1' ' HB ' ' A' ' 32' ' ' VAL . 0.4 OUTLIER -108.85 -20.86 12.91 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 177.681 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.661 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.99 166.64 10.33 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -170.87 109.02 0.32 Allowed 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 24' ' ' THR . 26.7 m-20 -147.32 -167.31 2.75 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.591 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.29 -6.13 12.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 108.814 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.631 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.4 m -88.2 6.94 34.27 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.352 -0.842 . . . . 0.0 109.145 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.83 -126.08 8.8 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.608 ' HB3' HG21 ' A' ' 21' ' ' VAL . 9.7 mt-30 -128.99 152.62 48.4 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.653 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -131.76 174.29 10.29 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.907 -1.121 . . . . 0.0 109.751 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -132.71 153.34 20.62 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.884 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 25.1 t -107.85 131.71 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.995 -1.297 . . . . 0.0 109.101 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.51 ' O ' ' CG ' ' A' ' 36' ' ' GLN . 44.0 mt-30 -150.33 132.8 15.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 109.564 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.466 ' HB3' ' HG2' ' A' ' 36' ' ' GLN . 13.1 t-20 63.02 16.01 8.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -0.868 . . . . 0.0 109.413 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.39 28.16 64.32 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.51 ' CG ' ' O ' ' A' ' 33' ' ' GLN . 0.8 OUTLIER -132.49 142.5 49.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.151 -1.205 . . . . 0.0 109.541 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.884 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.3 m95 -78.05 135.08 37.68 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.856 0.836 . . . . 0.0 111.976 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.471 ' HB2' ' C ' ' A' ' 12' ' ' CYS . 28.6 p -130.35 147.71 52.09 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.02 122.17 6.32 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.94 HD12 HG22 ' A' ' 21' ' ' VAL . 8.0 mt -88.3 120.33 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.401 -1.058 . . . . 0.0 108.967 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.49 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 26.7 t70 . . . . . 0 C--N 1.299 -1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 109.1 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.457 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -168.33 -152.16 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -43.83 103.38 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.158 -0.964 . . . . 0.0 109.671 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.619 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 6.2 p-90 -76.72 -31.0 56.88 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.192 -0.943 . . . . 0.0 109.685 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.731 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -57.99 -23.06 52.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 109.309 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.528 ' CG ' ' N ' ' A' ' 7' ' ' SER . 7.6 pt20 -54.14 -45.15 71.91 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.254 -0.904 . . . . 0.0 110.174 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.528 ' N ' ' CG ' ' A' ' 6' ' ' GLN . 28.0 t -43.36 -35.89 1.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 0.0 109.777 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.493 HE21 ' HB3' ' A' ' 8' ' ' GLN . 0.2 OUTLIER -89.98 -35.56 15.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.862 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.21 20.65 2.68 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.309 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.731 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 39.9 m-85 -94.11 169.67 10.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.937 -1.331 . . . . 0.0 109.081 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 0.9 OUTLIER -81.44 -151.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.051 -1.031 . . . . 0.0 110.845 -178.54 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.489 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 33.3 m -145.39 134.92 23.25 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.577 ' O ' ' CE2' ' A' ' 44' ' ' TYR . 5.3 m -75.21 131.85 40.7 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.152 -0.968 . . . . 0.0 110.434 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -70.84 130.42 41.62 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 49.88 84.49 0.2 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.083 -1.011 . . . . 0.0 108.704 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.631 ' CB ' HG23 ' A' ' 40' ' ' ILE . 34.2 Cg_endo -76.99 -16.4 15.98 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.736 2.291 . . . . 0.0 110.831 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -1.55 15.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.925 . . . . 0.0 109.964 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 m -143.79 29.38 1.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.02 -1.05 . . . . 0.0 109.99 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.542 HG22 HD11 ' A' ' 40' ' ' ILE . 2.6 m -115.94 97.92 6.36 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.135 -0.978 . . . . 0.0 109.417 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 19' ' ' THR . 2.0 mttt -43.87 120.12 1.94 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.905 HG22 HD12 ' A' ' 40' ' ' ILE . 38.7 t -71.81 127.34 33.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 110.721 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.416 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 6.1 mm-40 -109.28 -21.56 12.49 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.657 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.0 OUTLIER -102.71 167.67 9.75 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.61 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.3 m -170.71 108.72 0.32 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.88 -167.11 2.71 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.562 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.0 -6.21 12.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.102 -0.999 . . . . 0.0 108.968 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.619 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.69 8.27 32.47 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.33 -0.856 . . . . 0.0 109.159 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.01 -128.87 9.71 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.61 ' HG2' HG23 ' A' ' 24' ' ' THR . 47.2 mt-30 -127.85 150.65 49.75 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.649 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -128.28 178.55 6.17 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.839 -1.163 . . . . 0.0 109.923 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.456 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -135.84 151.04 20.54 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.864 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 37.9 t -105.48 133.73 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.945 -1.326 . . . . 0.0 109.148 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 68.8 mt-30 -154.23 135.38 13.96 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.453 -0.78 . . . . 0.0 109.577 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.47 ' HB3' ' HG2' ' A' ' 36' ' ' GLN . 3.9 t30 63.15 12.49 6.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.422 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.79 28.68 58.63 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.47 ' HG2' ' HB3' ' A' ' 34' ' ' ASN . 3.0 pt20 -135.69 142.74 45.14 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -1.159 . . . . 0.0 109.726 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.864 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.1 m95 -76.43 134.38 39.6 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.852 0.834 . . . . 0.0 111.989 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.489 ' HB2' ' C ' ' A' ' 12' ' ' CYS . 29.6 p -129.48 148.5 51.39 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.0 122.41 6.27 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.372 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.905 HD12 HG22 ' A' ' 21' ' ' VAL . 9.6 mt -89.87 120.24 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -1.039 . . . . 0.0 108.837 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.5 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 39.3 t0 -142.61 146.62 34.73 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 109.639 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -76.96 -37.28 55.52 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.213 -0.93 . . . . 0.0 109.583 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.0 m -74.85 -1.18 21.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.228 -0.92 . . . . 0.0 109.414 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.577 ' CE2' ' O ' ' A' ' 13' ' ' CYS . 7.1 t80 -73.38 99.57 2.98 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.235 -0.916 . . . . 0.0 109.122 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.94 -34.65 0.54 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.296 -1.12 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.436 ' HB1' ' OG ' ' A' ' 43' ' ' SER . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 4' ' ' TRP . 82.9 p -179.06 -153.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.465 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m -50.58 90.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.628 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.638 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 8.1 p-90 -74.66 -19.41 60.29 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.924 -1.11 . . . . 0.0 109.848 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.819 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -69.2 -28.27 66.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 109.502 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -49.52 -35.56 20.5 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 109.932 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 t -48.76 -45.82 40.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 109.786 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.431 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 6.8 mt-30 -84.86 -25.4 28.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.983 . . . . 0.0 109.656 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.21 45.35 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.819 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 53.3 m-85 -119.94 160.18 23.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -1.174 . . . . 0.0 108.922 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -75.44 -151.39 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.086 -1.009 . . . . 0.0 111.064 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.494 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 35.2 m -141.87 136.24 30.34 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.58 ' O ' ' CE2' ' A' ' 44' ' ' TYR . 9.2 m -75.57 133.78 40.87 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.058 -1.026 . . . . 0.0 110.232 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 15' ' ' ASN . 2.5 m-80 -71.21 133.85 46.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' ASN . 59.2 m-80 46.61 84.84 0.19 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.087 -1.008 . . . . 0.0 108.396 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.616 ' CB ' HG23 ' A' ' 40' ' ' ILE . 34.3 Cg_endo -75.94 -18.26 16.9 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.516 2.144 . . . . 0.0 110.875 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.7 m -74.59 0.46 14.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 109.798 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.85 22.33 1.77 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.019 -1.05 . . . . 0.0 109.831 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.587 HG22 HD11 ' A' ' 40' ' ' ILE . 2.8 m -107.72 98.52 8.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.151 -0.968 . . . . 0.0 109.262 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 19' ' ' THR . 8.8 mttp -43.56 118.58 1.41 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.355 -0.84 . . . . 0.0 109.128 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.923 HG22 HD12 ' A' ' 40' ' ' ILE . 40.5 t -71.72 125.56 30.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.461 -0.775 . . . . 0.0 110.663 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -108.55 -21.61 12.64 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.658 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 1.0 OUTLIER -102.5 167.82 9.69 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.443 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.656 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.1 m -170.84 109.36 0.33 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.451 ' OD2' ' CE2' ' A' ' 23' ' ' TYR . 3.3 m-20 -147.85 -167.28 2.75 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.638 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.45 -6.12 13.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.059 -1.026 . . . . 0.0 108.902 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.638 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.26 6.75 38.86 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.329 -0.857 . . . . 0.0 109.18 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.04 -129.55 9.93 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.656 ' HG2' HG23 ' A' ' 24' ' ' THR . 54.1 mt-30 -127.49 149.58 50.06 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.658 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -127.62 179.16 5.66 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.992 -1.068 . . . . 0.0 109.819 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.55 153.38 21.6 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.822 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 41.0 t -105.4 140.65 22.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.875 -1.368 . . . . 0.0 109.107 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.496 ' O ' ' CG ' ' A' ' 36' ' ' GLN . 2.6 mp0 -160.03 132.16 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 109.503 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 15.0 m-20 63.3 17.61 10.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.318 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.25 27.73 69.42 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.496 ' CG ' ' O ' ' A' ' 33' ' ' GLN . 3.5 pt20 -134.33 142.36 47.22 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.244 -1.15 . . . . 0.0 109.711 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.822 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.3 m95 -76.65 136.67 39.17 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.91 0.862 . . . . 0.0 112.025 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 29.9 p -130.64 150.6 51.76 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.74 121.76 6.39 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.628 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.923 HD12 HG22 ' A' ' 21' ' ' VAL . 10.8 mt -89.06 121.48 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.411 -1.052 . . . . 0.0 108.874 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.527 ' OD1' ' CD1' ' A' ' 4' ' ' TRP . 7.9 t0 -140.39 147.19 39.39 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.357 -0.839 . . . . 0.0 109.933 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -76.6 -39.98 50.92 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.324 -0.86 . . . . 0.0 109.505 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.436 ' OG ' ' HB1' ' A' ' 1' ' ' ALA . 69.3 m -81.94 6.8 14.8 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.281 -0.887 . . . . 0.0 109.224 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 13' ' ' CYS . 9.6 t80 -74.54 121.54 21.7 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.292 -0.88 . . . . 0.0 109.165 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 46' ' ' GLN . . . 109.51 -7.53 32.12 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 13.9 pm0 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.51 -0.994 . . . . 0.0 109.976 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.57 -164.72 0.18 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 109.452 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -48.87 99.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 109.713 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.635 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 5.9 p-90 -77.33 -21.95 52.64 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.207 -0.933 . . . . 0.0 109.568 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.834 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -63.65 -24.37 67.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.48 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -51.1 -31.69 20.06 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.249 -0.907 . . . . 0.0 110.002 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.34 -44.39 54.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 109.735 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.453 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 2.1 mt-30 -89.58 -25.08 21.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.09 45.6 0.86 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.834 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 44.8 m-85 -115.45 163.11 16.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -1.192 . . . . 0.0 108.864 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -75.23 -150.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.068 -1.02 . . . . 0.0 110.904 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.481 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 9.3 m -147.44 131.5 17.27 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.573 ' O ' ' CE2' ' A' ' 44' ' ' TYR . 5.0 m -71.6 137.03 47.66 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.096 -1.003 . . . . 0.0 110.306 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -80.61 129.75 34.7 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m120 59.63 90.03 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.978 . . . . 0.0 108.854 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.487 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 35.3 Cg_endo -77.41 -26.58 7.18 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.666 2.244 . . . . 0.0 111.007 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.5 p -72.58 0.34 10.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.266 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.5 p -142.08 28.61 1.7 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.901 -1.124 . . . . 0.0 110.124 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.62 HG22 HD11 ' A' ' 40' ' ' ILE . 3.0 m -120.27 96.91 5.34 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.002 -1.061 . . . . 0.0 109.448 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.44 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 28.8 mtmt -46.23 119.46 2.34 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.29 -0.881 . . . . 0.0 109.13 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.806 HG22 HD12 ' A' ' 40' ' ' ILE . 40.3 t -70.08 126.66 30.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.503 -0.748 . . . . 0.0 110.449 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.44 ' OE2' ' O ' ' A' ' 20' ' ' LYS . 6.9 mm-40 -109.02 -21.75 12.48 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.661 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.98 167.51 9.79 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.637 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.1 m -170.81 109.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.572 ' OD1' ' CE2' ' A' ' 23' ' ' TYR . 3.5 m-20 -148.6 -165.18 2.2 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.773 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.33 -5.47 14.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.21 -0.931 . . . . 0.0 108.847 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.635 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.4 m -90.86 7.45 39.88 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.342 -0.849 . . . . 0.0 109.169 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.25 -127.81 9.36 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.637 ' HG2' HG23 ' A' ' 24' ' ' THR . 55.6 mt-30 -129.22 150.06 50.76 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.651 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -128.15 179.27 5.69 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.952 -1.092 . . . . 0.0 109.826 -179.151 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.22 153.36 21.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.863 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 37.1 t -107.85 134.54 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.983 -1.304 . . . . 0.0 109.208 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 73.1 mt-30 -159.72 144.6 15.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.548 -0.72 . . . . 0.0 109.582 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.526 ' CB ' ' OE1' ' A' ' 36' ' ' GLN . 0.9 OUTLIER 59.42 14.99 4.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.76 34.61 62.52 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.526 ' OE1' ' CB ' ' A' ' 34' ' ' ASN . 0.3 OUTLIER -145.94 148.55 32.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.153 -1.204 . . . . 0.0 109.722 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.863 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.3 m95 -78.27 136.75 37.82 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.911 0.862 . . . . 0.0 112.041 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.495 ' HB2' ' N ' ' A' ' 13' ' ' CYS . 28.3 p -131.39 146.24 52.18 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.59 123.02 6.31 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.806 HD12 HG22 ' A' ' 21' ' ' VAL . 6.2 mt -89.28 118.07 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.362 -1.081 . . . . 0.0 109.035 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 24.7 t70 -128.81 137.98 51.81 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.368 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -72.94 -36.94 67.3 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.145 -0.972 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.39 -10.41 59.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.222 -0.924 . . . . 0.0 108.987 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.573 ' CE2' ' O ' ' A' ' 13' ' ' CYS . 10.9 t80 -75.93 136.82 40.07 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.377 -0.827 . . . . 0.0 109.158 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.45 -55.36 0.17 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.245 -1.15 . . . . 0.0 109.439 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.401 ' C ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.401 ' OG ' ' C ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -179.59 -163.85 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.56 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -43.38 102.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.798 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.632 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 6.4 p-90 -77.17 -25.57 52.04 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 109.726 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.823 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -60.36 -24.13 64.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.405 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.77 -32.56 52.85 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.103 -0.998 . . . . 0.0 109.734 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.3 t -45.63 -41.32 10.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.524 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -94.04 -33.39 13.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 109.669 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.74 28.66 1.25 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.703 -1.236 . . . . 0.0 110.248 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.823 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 46.7 m-85 -95.56 166.99 11.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.084 -1.245 . . . . 0.0 108.946 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.5 m120 -79.47 -151.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.001 -1.062 . . . . 0.0 110.956 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.504 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 30.6 m -145.28 133.99 22.24 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.582 ' O ' ' CE2' ' A' ' 44' ' ' TYR . 6.6 m -73.02 138.46 45.98 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.129 -0.982 . . . . 0.0 110.425 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.2 m-20 -77.9 134.54 37.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 48.41 80.45 0.3 Allowed Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.963 -1.086 . . . . 0.0 108.429 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.421 ' CB ' HG23 ' A' ' 40' ' ' ILE . 34.9 Cg_endo -76.4 -15.45 17.75 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.695 2.264 . . . . 0.0 110.861 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -70.83 -3.14 17.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.128 -0.983 . . . . 0.0 109.937 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 93.9 p -146.81 29.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 0.0 109.925 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.659 HG22 HD11 ' A' ' 40' ' ' ILE . 3.4 m -106.78 98.78 8.4 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.145 -0.972 . . . . 0.0 109.325 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 19' ' ' THR . 14.7 mttt -43.52 119.0 1.5 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.816 . . . . 0.0 109.179 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.784 HG22 HD12 ' A' ' 40' ' ' ILE . 42.8 t -73.29 124.29 30.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 110.834 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.93 -21.76 12.7 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.655 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.16 167.45 10.0 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.586 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.3 m -170.78 109.03 0.32 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.43 -167.53 2.81 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.396 -0.921 . . . . 0.0 109.685 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.36 -6.07 12.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.011 . . . . 0.0 108.87 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.632 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.69 7.61 35.81 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.326 -0.859 . . . . 0.0 109.076 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.3 -129.73 9.99 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.586 ' HG2' HG23 ' A' ' 24' ' ' THR . 61.2 mt-30 -127.04 150.02 49.64 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.649 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -128.35 178.54 6.2 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.907 -1.121 . . . . 0.0 109.806 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.01 154.66 22.0 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.826 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 41.6 t -106.97 139.67 27.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.841 -1.387 . . . . 0.0 109.068 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 1.2 mp0 -162.24 139.15 8.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.488 -0.757 . . . . 0.0 109.536 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.95 13.03 5.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.46 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.05 30.4 59.17 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 33' ' ' GLN . 22.2 pt20 -141.16 146.32 36.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -1.203 . . . . 0.0 109.63 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.826 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.4 m95 -76.53 137.28 39.49 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.843 0.83 . . . . 0.0 112.024 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.504 ' HB2' ' C ' ' A' ' 12' ' ' CYS . 29.7 p -131.17 147.7 52.63 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.13 123.33 6.52 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.784 HD12 HG22 ' A' ' 21' ' ' VAL . 6.2 mt -90.51 117.7 34.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.302 -1.117 . . . . 0.0 108.955 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -137.88 148.04 45.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -78.04 -34.69 50.42 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.337 -0.852 . . . . 0.0 109.523 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.465 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 0.3 OUTLIER -75.91 -0.33 21.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.336 179.658 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.582 ' CE2' ' O ' ' A' ' 13' ' ' CYS . 22.3 t80 -80.0 150.91 30.27 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.318 -0.864 . . . . 0.0 109.154 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.01 56.31 17.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 43' ' ' SER . 5.5 mt-30 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.265 -1.138 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.524 ' CB ' ' OD2' ' A' ' 41' ' ' ASP . 66.8 m -83.4 9.1 11.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.553 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.12 106.52 1.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.554 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.631 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 7.1 p-90 -76.76 -26.38 54.48 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.808 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.776 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -64.09 -22.87 67.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.529 ' CG ' ' N ' ' A' ' 7' ' ' SER . 6.6 pt20 -53.75 -44.8 70.26 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.529 ' N ' ' CG ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -46.01 -35.35 4.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.014 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -90.75 -29.97 17.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.056 -1.027 . . . . 0.0 109.922 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.25 39.33 0.95 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.776 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 49.9 m-85 -116.34 161.09 19.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -1.199 . . . . 0.0 108.923 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -73.75 -150.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.09 -1.006 . . . . 0.0 110.947 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.471 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 24.7 m -147.08 132.5 18.61 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.579 ' O ' ' CE2' ' A' ' 44' ' ' TYR . 5.0 m -73.67 133.94 43.51 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.191 -0.943 . . . . 0.0 110.382 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -76.74 132.02 39.06 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.7 m120 55.54 91.05 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.055 -1.028 . . . . 0.0 108.821 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.555 ' HB3' HG23 ' A' ' 40' ' ' ILE . 35.1 Cg_endo -77.25 -28.72 5.5 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.705 2.27 . . . . 0.0 110.877 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.13 -2.71 13.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.137 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.8 34.46 1.98 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 0.0 110.095 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.558 HG22 HD11 ' A' ' 40' ' ' ILE . 2.1 m -125.51 96.63 4.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.981 -1.075 . . . . 0.0 109.36 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 19' ' ' THR . 9.1 mttm -44.61 117.74 1.38 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.396 -0.815 . . . . 0.0 109.196 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.94 HG22 HD12 ' A' ' 40' ' ' ILE . 38.9 t -73.29 126.94 34.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.454 -0.779 . . . . 0.0 110.712 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.466 ' OE1' ' HB ' ' A' ' 32' ' ' VAL . 0.4 OUTLIER -108.85 -20.86 12.91 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 177.681 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.661 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.99 166.64 10.33 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -170.87 109.02 0.32 Allowed 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 24' ' ' THR . 26.7 m-20 -147.32 -167.31 2.75 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.591 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.29 -6.13 12.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 108.814 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.631 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.4 m -88.2 6.94 34.27 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.352 -0.842 . . . . 0.0 109.145 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.83 -126.08 8.8 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.608 ' HB3' HG21 ' A' ' 21' ' ' VAL . 9.7 mt-30 -128.99 152.62 48.4 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.653 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -131.76 174.29 10.29 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.907 -1.121 . . . . 0.0 109.751 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -132.71 153.34 20.62 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.884 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 25.1 t -107.85 131.71 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.995 -1.297 . . . . 0.0 109.101 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.51 ' O ' ' CG ' ' A' ' 36' ' ' GLN . 44.0 mt-30 -150.33 132.8 15.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 109.564 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.466 ' HB3' ' HG2' ' A' ' 36' ' ' GLN . 13.1 t-20 63.02 16.01 8.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -0.868 . . . . 0.0 109.413 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.39 28.16 64.32 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.51 ' CG ' ' O ' ' A' ' 33' ' ' GLN . 0.8 OUTLIER -132.49 142.5 49.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.151 -1.205 . . . . 0.0 109.541 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.884 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.3 m95 -78.05 135.08 37.68 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.856 0.836 . . . . 0.0 111.976 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.471 ' HB2' ' C ' ' A' ' 12' ' ' CYS . 28.6 p -130.35 147.71 52.09 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.02 122.17 6.32 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.94 HD12 HG22 ' A' ' 21' ' ' VAL . 8.0 mt -88.3 120.33 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.401 -1.058 . . . . 0.0 108.967 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.524 ' OD2' ' CB ' ' A' ' 2' ' ' SER . 26.7 t70 -129.6 134.84 47.93 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 109.1 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 5.9 m-85 -69.61 -36.79 76.49 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.191 -0.943 . . . . 0.0 109.485 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 2' ' ' SER . 47.9 t -76.7 -9.64 58.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.927 . . . . 0.0 109.062 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.579 ' CE2' ' O ' ' A' ' 13' ' ' CYS . 8.4 t80 -76.04 115.7 16.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.366 -0.834 . . . . 0.0 109.17 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.59 -11.43 61.61 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 1.6 mt-30 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.19 -1.182 . . . . 0.0 109.423 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.341 0.591 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.619 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 6.2 p-90 -76.72 -31.0 56.88 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.192 -0.943 . . . . 0.0 109.685 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.731 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -57.99 -23.06 52.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 109.309 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.528 ' CG ' ' N ' ' A' ' 7' ' ' SER . 7.6 pt20 -54.14 -45.15 71.91 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.254 -0.904 . . . . 0.0 110.174 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.528 ' N ' ' CG ' ' A' ' 6' ' ' GLN . 28.0 t -43.36 -35.89 1.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 0.0 109.777 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -89.98 -35.56 15.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.862 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.21 20.65 2.68 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.309 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.731 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 39.9 m-85 -94.11 169.67 10.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.937 -1.331 . . . . 0.0 109.081 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 0.9 OUTLIER -81.44 -151.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.051 -1.031 . . . . 0.0 110.845 -178.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.489 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 33.3 m -145.39 134.92 23.25 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.519 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 5.3 m -75.21 131.85 40.7 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.152 -0.968 . . . . 0.0 110.434 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -70.84 130.42 41.62 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 49.88 84.49 0.2 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.083 -1.011 . . . . 0.0 108.704 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.631 ' CB ' HG23 ' A' ' 40' ' ' ILE . 34.2 Cg_endo -76.99 -16.4 15.98 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.736 2.291 . . . . 0.0 110.831 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -1.55 15.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.925 . . . . 0.0 109.964 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 m -143.79 29.38 1.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.02 -1.05 . . . . 0.0 109.99 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.542 HG22 HD11 ' A' ' 40' ' ' ILE . 2.6 m -115.94 97.92 6.36 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.135 -0.978 . . . . 0.0 109.417 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 19' ' ' THR . 2.0 mttt -43.87 120.12 1.94 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.905 HG22 HD12 ' A' ' 40' ' ' ILE . 38.7 t -71.81 127.34 33.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 110.721 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.416 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 6.1 mm-40 -109.28 -21.56 12.49 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.657 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.0 OUTLIER -102.71 167.67 9.75 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.61 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.3 m -170.71 108.72 0.32 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.88 -167.11 2.71 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.562 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.0 -6.21 12.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.102 -0.999 . . . . 0.0 108.968 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.619 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.69 8.27 32.47 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.33 -0.856 . . . . 0.0 109.159 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.01 -128.87 9.71 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.61 ' HG2' HG23 ' A' ' 24' ' ' THR . 47.2 mt-30 -127.85 150.65 49.75 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.649 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -128.28 178.55 6.17 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.839 -1.163 . . . . 0.0 109.923 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.456 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -135.84 151.04 20.54 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.864 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 37.9 t -105.48 133.73 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.945 -1.326 . . . . 0.0 109.148 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 68.8 mt-30 -154.23 135.38 13.96 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.453 -0.78 . . . . 0.0 109.577 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.47 ' HB3' ' HG2' ' A' ' 36' ' ' GLN . 3.9 t30 63.15 12.49 6.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.422 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.79 28.68 58.63 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.47 ' HG2' ' HB3' ' A' ' 34' ' ' ASN . 3.0 pt20 -135.69 142.74 45.14 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -1.159 . . . . 0.0 109.726 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.864 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.1 m95 -76.43 134.38 39.6 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.852 0.834 . . . . 0.0 111.989 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.489 ' HB2' ' C ' ' A' ' 12' ' ' CYS . 29.6 p -129.48 148.5 51.39 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.0 122.41 6.27 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.372 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.905 HD12 HG22 ' A' ' 21' ' ' VAL . 9.6 mt -89.87 120.24 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -1.039 . . . . 0.0 108.837 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.5 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 39.3 t0 . . . . . 0 C--N 1.299 -1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 109.639 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.638 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 8.1 p-90 -74.66 -19.41 60.29 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.924 -1.11 . . . . 0.0 109.848 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.819 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -69.2 -28.27 66.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 109.502 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -49.52 -35.56 20.5 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 109.932 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 t -48.76 -45.82 40.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 109.786 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.431 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 6.8 mt-30 -84.86 -25.4 28.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.983 . . . . 0.0 109.656 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.21 45.35 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.819 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 53.3 m-85 -119.94 160.18 23.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -1.174 . . . . 0.0 108.922 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.446 ' N ' ' ND2' ' A' ' 11' ' ' ASN . 2.2 m120 -75.44 -151.39 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.086 -1.009 . . . . 0.0 111.064 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.494 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 35.2 m -141.87 136.24 30.34 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.525 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 9.2 m -75.57 133.78 40.87 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.058 -1.026 . . . . 0.0 110.232 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 15' ' ' ASN . 2.5 m-80 -71.21 133.85 46.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' ASN . 59.2 m-80 46.61 84.84 0.19 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.087 -1.008 . . . . 0.0 108.396 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.616 ' CB ' HG23 ' A' ' 40' ' ' ILE . 34.3 Cg_endo -75.94 -18.26 16.9 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.516 2.144 . . . . 0.0 110.875 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.7 m -74.59 0.46 14.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 109.798 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.85 22.33 1.77 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.019 -1.05 . . . . 0.0 109.831 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.587 HG22 HD11 ' A' ' 40' ' ' ILE . 2.8 m -107.72 98.52 8.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.151 -0.968 . . . . 0.0 109.262 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 19' ' ' THR . 8.8 mttp -43.56 118.58 1.41 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.355 -0.84 . . . . 0.0 109.128 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.923 HG22 HD12 ' A' ' 40' ' ' ILE . 40.5 t -71.72 125.56 30.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.461 -0.775 . . . . 0.0 110.663 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -108.55 -21.61 12.64 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.658 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 1.0 OUTLIER -102.5 167.82 9.69 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.656 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.1 m -170.84 109.36 0.33 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.451 ' OD2' ' CE2' ' A' ' 23' ' ' TYR . 3.3 m-20 -147.85 -167.28 2.75 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.638 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.45 -6.12 13.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.059 -1.026 . . . . 0.0 108.902 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.638 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.26 6.75 38.86 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.329 -0.857 . . . . 0.0 109.18 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.04 -129.55 9.93 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.656 ' HG2' HG23 ' A' ' 24' ' ' THR . 54.1 mt-30 -127.49 149.58 50.06 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.658 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -127.62 179.16 5.66 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.992 -1.068 . . . . 0.0 109.819 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.55 153.38 21.6 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.822 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 41.0 t -105.4 140.65 22.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.875 -1.368 . . . . 0.0 109.107 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.496 ' O ' ' CG ' ' A' ' 36' ' ' GLN . 2.6 mp0 -160.03 132.16 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 109.503 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 15.0 m-20 63.3 17.61 10.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.318 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.25 27.73 69.42 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.496 ' CG ' ' O ' ' A' ' 33' ' ' GLN . 1.2 pt20 -134.33 142.36 47.22 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.244 -1.15 . . . . 0.0 109.711 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.822 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.3 m95 -76.65 136.67 39.17 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.91 0.862 . . . . 0.0 112.025 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 29.9 p -130.64 150.6 51.76 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.74 121.76 6.39 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.628 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.923 HD12 HG22 ' A' ' 21' ' ' VAL . 10.8 mt -89.06 121.48 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.411 -1.052 . . . . 0.0 108.874 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.527 ' OD1' ' CD1' ' A' ' 4' ' ' TRP . 7.9 t0 . . . . . 0 C--N 1.3 -1.558 0 O-C-N 121.357 -0.839 . . . . 0.0 109.933 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.319 0.581 . . . . 0.0 109.713 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.635 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 5.9 p-90 -77.33 -21.95 52.64 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.207 -0.933 . . . . 0.0 109.568 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.834 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -63.65 -24.37 67.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.48 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -51.1 -31.69 20.06 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.249 -0.907 . . . . 0.0 110.002 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.34 -44.39 54.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 109.735 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.453 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 6.7 mt-30 -89.58 -25.08 21.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.09 45.6 0.86 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.834 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 44.8 m-85 -115.45 163.11 16.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -1.192 . . . . 0.0 108.864 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -75.23 -150.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.068 -1.02 . . . . 0.0 110.904 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.481 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 9.3 m -147.44 131.5 17.27 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.522 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 5.0 m -71.6 137.03 47.66 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.096 -1.003 . . . . 0.0 110.306 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -80.61 129.75 34.7 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.63 90.03 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.978 . . . . 0.0 108.854 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.487 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 35.3 Cg_endo -77.41 -26.58 7.18 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.666 2.244 . . . . 0.0 111.007 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.5 p -72.58 0.34 10.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.266 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.5 p -142.08 28.61 1.7 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.901 -1.124 . . . . 0.0 110.124 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.62 HG22 HD11 ' A' ' 40' ' ' ILE . 3.0 m -120.27 96.91 5.34 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.002 -1.061 . . . . 0.0 109.448 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.44 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 28.8 mtmt -46.23 119.46 2.34 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.29 -0.881 . . . . 0.0 109.13 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.806 HG22 HD12 ' A' ' 40' ' ' ILE . 40.3 t -70.08 126.66 30.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.503 -0.748 . . . . 0.0 110.449 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.44 ' OE2' ' O ' ' A' ' 20' ' ' LYS . 6.9 mm-40 -109.02 -21.75 12.48 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.661 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.98 167.51 9.79 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.637 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.1 m -170.81 109.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.572 ' OD1' ' CE2' ' A' ' 23' ' ' TYR . 3.5 m-20 -148.6 -165.18 2.2 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.773 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.33 -5.47 14.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.21 -0.931 . . . . 0.0 108.847 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.635 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.4 m -90.86 7.45 39.88 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.342 -0.849 . . . . 0.0 109.169 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.25 -127.81 9.36 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.637 ' HG2' HG23 ' A' ' 24' ' ' THR . 55.6 mt-30 -129.22 150.06 50.76 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.651 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -128.15 179.27 5.69 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.952 -1.092 . . . . 0.0 109.826 -179.151 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.22 153.36 21.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.863 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 37.1 t -107.85 134.54 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.983 -1.304 . . . . 0.0 109.208 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 73.1 mt-30 -159.72 144.6 15.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.548 -0.72 . . . . 0.0 109.582 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.526 ' CB ' ' OE1' ' A' ' 36' ' ' GLN . 0.9 OUTLIER 59.42 14.99 4.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.76 34.61 62.52 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.526 ' OE1' ' CB ' ' A' ' 34' ' ' ASN . 0.3 OUTLIER -145.94 148.55 32.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.153 -1.204 . . . . 0.0 109.722 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.863 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.3 m95 -78.27 136.75 37.82 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.911 0.862 . . . . 0.0 112.041 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.495 ' HB2' ' N ' ' A' ' 13' ' ' CYS . 28.3 p -131.39 146.24 52.18 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.59 123.02 6.31 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.806 HD12 HG22 ' A' ' 21' ' ' VAL . 6.2 mt -89.28 118.07 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.362 -1.081 . . . . 0.0 109.035 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 24.7 t70 . . . . . 0 C--N 1.3 -1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.368 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.296 0.569 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.632 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 6.4 p-90 -77.17 -25.57 52.04 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 109.726 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.823 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -60.36 -24.13 64.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.405 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.77 -32.56 52.85 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.103 -0.998 . . . . 0.0 109.734 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.3 t -45.63 -41.32 10.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.524 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -94.04 -33.39 13.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 109.669 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.74 28.66 1.25 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.703 -1.236 . . . . 0.0 110.248 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.823 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 46.7 m-85 -95.56 166.99 11.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.084 -1.245 . . . . 0.0 108.946 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.5 m120 -79.47 -151.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.001 -1.062 . . . . 0.0 110.956 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.504 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 30.6 m -145.28 133.99 22.24 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.519 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 6.6 m -73.02 138.46 45.98 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.129 -0.982 . . . . 0.0 110.425 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.2 m-20 -77.9 134.54 37.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 48.41 80.45 0.3 Allowed Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.963 -1.086 . . . . 0.0 108.429 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.421 ' CB ' HG23 ' A' ' 40' ' ' ILE . 34.9 Cg_endo -76.4 -15.45 17.75 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.695 2.264 . . . . 0.0 110.861 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -70.83 -3.14 17.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.128 -0.983 . . . . 0.0 109.937 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 93.9 p -146.81 29.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 0.0 109.925 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.659 HG22 HD11 ' A' ' 40' ' ' ILE . 3.4 m -106.78 98.78 8.4 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.145 -0.972 . . . . 0.0 109.325 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 19' ' ' THR . 14.7 mttt -43.52 119.0 1.5 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.816 . . . . 0.0 109.179 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.784 HG22 HD12 ' A' ' 40' ' ' ILE . 42.8 t -73.29 124.29 30.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 110.834 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.93 -21.76 12.7 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.655 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.16 167.45 10.0 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.586 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.3 m -170.78 109.03 0.32 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.43 -167.53 2.81 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.396 -0.921 . . . . 0.0 109.685 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.36 -6.07 12.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.011 . . . . 0.0 108.87 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.632 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.69 7.61 35.81 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.326 -0.859 . . . . 0.0 109.076 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.3 -129.73 9.99 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.586 ' HG2' HG23 ' A' ' 24' ' ' THR . 61.2 mt-30 -127.04 150.02 49.64 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.649 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -128.35 178.54 6.2 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.907 -1.121 . . . . 0.0 109.806 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.01 154.66 22.0 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.826 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 41.6 t -106.97 139.67 27.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.841 -1.387 . . . . 0.0 109.068 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 1.2 mp0 -162.24 139.15 8.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.488 -0.757 . . . . 0.0 109.536 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.95 13.03 5.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.46 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.05 30.4 59.17 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 33' ' ' GLN . 4.5 pt20 -141.16 146.32 36.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -1.203 . . . . 0.0 109.63 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.826 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.4 m95 -76.53 137.28 39.49 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.843 0.83 . . . . 0.0 112.024 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.504 ' HB2' ' C ' ' A' ' 12' ' ' CYS . 29.7 p -131.17 147.7 52.63 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.13 123.33 6.52 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.784 HD12 HG22 ' A' ' 21' ' ' VAL . 6.2 mt -90.51 117.7 34.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.302 -1.117 . . . . 0.0 108.955 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t0 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 -179.648 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.272 0.558 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.631 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 7.1 p-90 -76.76 -26.38 54.48 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.808 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.776 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -64.09 -22.87 67.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.529 ' CG ' ' N ' ' A' ' 7' ' ' SER . 6.6 pt20 -53.75 -44.8 70.26 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.529 ' N ' ' CG ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -46.01 -35.35 4.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.014 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -90.75 -29.97 17.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.056 -1.027 . . . . 0.0 109.922 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.25 39.33 0.95 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.776 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 49.9 m-85 -116.34 161.09 19.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -1.199 . . . . 0.0 108.923 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -73.75 -150.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.09 -1.006 . . . . 0.0 110.947 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.471 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 24.7 m -147.08 132.5 18.61 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.526 ' SG ' ' CG1' ' A' ' 40' ' ' ILE . 5.0 m -73.67 133.94 43.51 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.191 -0.943 . . . . 0.0 110.382 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -76.74 132.02 39.06 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.7 m120 55.54 91.05 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.055 -1.028 . . . . 0.0 108.821 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.555 ' HB3' HG23 ' A' ' 40' ' ' ILE . 35.1 Cg_endo -77.25 -28.72 5.5 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.705 2.27 . . . . 0.0 110.877 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.13 -2.71 13.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.137 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.8 34.46 1.98 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 0.0 110.095 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.558 HG22 HD11 ' A' ' 40' ' ' ILE . 2.1 m -125.51 96.63 4.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.981 -1.075 . . . . 0.0 109.36 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 19' ' ' THR . 9.1 mttm -44.61 117.74 1.38 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.396 -0.815 . . . . 0.0 109.196 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.94 HG22 HD12 ' A' ' 40' ' ' ILE . 38.9 t -73.29 126.94 34.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.454 -0.779 . . . . 0.0 110.712 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.466 ' OE1' ' HB ' ' A' ' 32' ' ' VAL . 0.4 OUTLIER -108.85 -20.86 12.91 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 177.681 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.661 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.99 166.64 10.33 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -170.87 109.02 0.32 Allowed 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 24' ' ' THR . 26.7 m-20 -147.32 -167.31 2.75 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.591 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.29 -6.13 12.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 108.814 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.631 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.4 m -88.2 6.94 34.27 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.352 -0.842 . . . . 0.0 109.145 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.83 -126.08 8.8 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.608 ' HB3' HG21 ' A' ' 21' ' ' VAL . 9.7 mt-30 -128.99 152.62 48.4 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.653 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -131.76 174.29 10.29 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.907 -1.121 . . . . 0.0 109.751 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -132.71 153.34 20.62 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.884 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 25.1 t -107.85 131.71 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.995 -1.297 . . . . 0.0 109.101 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.51 ' O ' ' CG ' ' A' ' 36' ' ' GLN . 44.0 mt-30 -150.33 132.8 15.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 109.564 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.466 ' HB3' ' HG2' ' A' ' 36' ' ' GLN . 13.1 t-20 63.02 16.01 8.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -0.868 . . . . 0.0 109.413 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.39 28.16 64.32 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.51 ' CG ' ' O ' ' A' ' 33' ' ' GLN . 0.8 OUTLIER -132.49 142.5 49.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.151 -1.205 . . . . 0.0 109.541 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.884 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.3 m95 -78.05 135.08 37.68 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.856 0.836 . . . . 0.0 111.976 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.471 ' HB2' ' C ' ' A' ' 12' ' ' CYS . 28.6 p -130.35 147.71 52.09 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.02 122.17 6.32 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.94 HD12 HG22 ' A' ' 21' ' ' VAL . 8.0 mt -88.3 120.33 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.401 -1.058 . . . . 0.0 108.967 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.49 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 26.7 t70 . . . . . 0 C--N 1.299 -1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 109.1 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.457 ' O ' ' OD2' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -168.33 -152.16 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -43.83 103.38 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.158 -0.964 . . . . 0.0 109.671 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.619 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 6.2 p-90 -76.72 -31.0 56.88 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.192 -0.943 . . . . 0.0 109.685 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.731 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -57.99 -23.06 52.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 109.309 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.528 ' CG ' ' N ' ' A' ' 7' ' ' SER . 7.6 pt20 -54.14 -45.15 71.91 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.254 -0.904 . . . . 0.0 110.174 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.528 ' N ' ' CG ' ' A' ' 6' ' ' GLN . 28.0 t -43.36 -35.89 1.7 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 0.0 109.777 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -89.98 -35.56 15.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 0.0 109.862 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.21 20.65 2.68 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.764 -1.208 . . . . 0.0 110.309 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.731 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 39.9 m-85 -94.11 169.67 10.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.937 -1.331 . . . . 0.0 109.081 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 0.9 OUTLIER -81.44 -151.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.051 -1.031 . . . . 0.0 110.845 -178.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.489 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 33.3 m -145.39 134.92 23.25 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.577 ' O ' ' CE2' ' A' ' 44' ' ' TYR . 5.3 m -75.21 131.85 40.7 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.152 -0.968 . . . . 0.0 110.434 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -70.84 130.42 41.62 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 49.88 84.49 0.2 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.083 -1.011 . . . . 0.0 108.704 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.631 ' CB ' HG23 ' A' ' 40' ' ' ILE . 34.2 Cg_endo -76.99 -16.4 15.98 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.736 2.291 . . . . 0.0 110.831 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -72.32 -1.55 15.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.925 . . . . 0.0 109.964 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.4 m -143.79 29.38 1.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.02 -1.05 . . . . 0.0 109.99 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.542 HG22 HD11 ' A' ' 40' ' ' ILE . 2.6 m -115.94 97.92 6.36 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.135 -0.978 . . . . 0.0 109.417 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 19' ' ' THR . 2.0 mttt -43.87 120.12 1.94 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.383 -0.823 . . . . 0.0 109.128 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.905 HG22 HD12 ' A' ' 40' ' ' ILE . 38.7 t -71.81 127.34 33.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.518 -0.739 . . . . 0.0 110.721 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.416 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 6.1 mm-40 -109.28 -21.56 12.49 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.657 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.0 OUTLIER -102.71 167.67 9.75 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.61 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.3 m -170.71 108.72 0.32 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.88 -167.11 2.71 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 119.517 -0.873 . . . . 0.0 109.562 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.0 -6.21 12.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.102 -0.999 . . . . 0.0 108.968 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.619 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.69 8.27 32.47 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.33 -0.856 . . . . 0.0 109.159 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.01 -128.87 9.71 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.61 ' HG2' HG23 ' A' ' 24' ' ' THR . 47.2 mt-30 -127.85 150.65 49.75 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.649 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -128.28 178.55 6.17 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.839 -1.163 . . . . 0.0 109.923 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.456 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -135.84 151.04 20.54 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.864 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 37.9 t -105.48 133.73 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.945 -1.326 . . . . 0.0 109.148 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 68.8 mt-30 -154.23 135.38 13.96 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.453 -0.78 . . . . 0.0 109.577 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.47 ' HB3' ' HG2' ' A' ' 36' ' ' GLN . 3.9 t30 63.15 12.49 6.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 0.0 109.422 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.79 28.68 58.63 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.47 ' HG2' ' HB3' ' A' ' 34' ' ' ASN . 3.0 pt20 -135.69 142.74 45.14 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.23 -1.159 . . . . 0.0 109.726 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.864 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.1 m95 -76.43 134.38 39.6 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-O 121.852 0.834 . . . . 0.0 111.989 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.489 ' HB2' ' C ' ' A' ' 12' ' ' CYS . 29.6 p -129.48 148.5 51.39 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.0 122.41 6.27 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.99 -1.1 . . . . 0.0 110.372 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.905 HD12 HG22 ' A' ' 21' ' ' VAL . 9.6 mt -89.87 120.24 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.434 -1.039 . . . . 0.0 108.837 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.5 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 39.3 t0 -142.61 146.62 34.73 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 109.639 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -76.96 -37.28 55.52 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.213 -0.93 . . . . 0.0 109.583 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.0 m -74.85 -1.18 21.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.228 -0.92 . . . . 0.0 109.414 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.577 ' CE2' ' O ' ' A' ' 13' ' ' CYS . 7.1 t80 -73.38 99.57 2.98 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.235 -0.916 . . . . 0.0 109.122 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.94 -34.65 0.54 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.296 -1.12 . . . . 0.0 109.548 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.436 ' HB1' ' OG ' ' A' ' 43' ' ' SER . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 4' ' ' TRP . 82.9 p -179.06 -153.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.465 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 72.1 m -50.58 90.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.628 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.638 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 8.1 p-90 -74.66 -19.41 60.29 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.924 -1.11 . . . . 0.0 109.848 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.819 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -69.2 -28.27 66.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 109.502 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -49.52 -35.56 20.5 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.175 -0.953 . . . . 0.0 109.932 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.4 t -48.76 -45.82 40.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 109.786 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.431 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 6.8 mt-30 -84.86 -25.4 28.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -0.983 . . . . 0.0 109.656 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.21 45.35 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.819 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 53.3 m-85 -119.94 160.18 23.22 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -1.174 . . . . 0.0 108.922 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.446 ' N ' ' ND2' ' A' ' 11' ' ' ASN . 2.2 m120 -75.44 -151.39 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.086 -1.009 . . . . 0.0 111.064 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.494 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 35.2 m -141.87 136.24 30.34 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.58 ' O ' ' CE2' ' A' ' 44' ' ' TYR . 9.2 m -75.57 133.78 40.87 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.058 -1.026 . . . . 0.0 110.232 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 15' ' ' ASN . 2.5 m-80 -71.21 133.85 46.45 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 14' ' ' ASN . 59.2 m-80 46.61 84.84 0.19 Allowed Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.087 -1.008 . . . . 0.0 108.396 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.616 ' CB ' HG23 ' A' ' 40' ' ' ILE . 34.3 Cg_endo -75.94 -18.26 16.9 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.516 2.144 . . . . 0.0 110.875 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.7 m -74.59 0.46 14.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 0.0 109.798 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.85 22.33 1.77 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.019 -1.05 . . . . 0.0 109.831 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.587 HG22 HD11 ' A' ' 40' ' ' ILE . 2.8 m -107.72 98.52 8.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.151 -0.968 . . . . 0.0 109.262 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 19' ' ' THR . 8.8 mttp -43.56 118.58 1.41 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.355 -0.84 . . . . 0.0 109.128 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.923 HG22 HD12 ' A' ' 40' ' ' ILE . 40.5 t -71.72 125.56 30.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 O-C-N 121.461 -0.775 . . . . 0.0 110.663 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -108.55 -21.61 12.64 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.658 ' CB ' ' HB2' ' A' ' 30' ' ' TRP . 1.0 OUTLIER -102.5 167.82 9.69 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.656 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.1 m -170.84 109.36 0.33 Allowed 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.451 ' OD2' ' CE2' ' A' ' 23' ' ' TYR . 3.3 m-20 -147.85 -167.28 2.75 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.638 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.45 -6.12 13.49 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.059 -1.026 . . . . 0.0 108.902 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.638 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.26 6.75 38.86 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.329 -0.857 . . . . 0.0 109.18 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.04 -129.55 9.93 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.656 ' HG2' HG23 ' A' ' 24' ' ' THR . 54.1 mt-30 -127.49 149.58 50.06 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.658 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -127.62 179.16 5.66 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.992 -1.068 . . . . 0.0 109.819 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.55 153.38 21.6 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.123 -1.991 . . . . 0.0 108.123 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.822 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 41.0 t -105.4 140.65 22.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.875 -1.368 . . . . 0.0 109.107 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.496 ' O ' ' CG ' ' A' ' 36' ' ' GLN . 2.6 mp0 -160.03 132.16 6.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.433 -0.792 . . . . 0.0 109.503 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 33' ' ' GLN . 15.0 m-20 63.3 17.61 10.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.318 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.25 27.73 69.42 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.496 ' CG ' ' O ' ' A' ' 33' ' ' GLN . 1.2 pt20 -134.33 142.36 47.22 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.244 -1.15 . . . . 0.0 109.711 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.822 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.3 m95 -76.65 136.67 39.17 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.91 0.862 . . . . 0.0 112.025 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 29.9 p -130.64 150.6 51.76 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -90.74 121.76 6.39 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.628 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.923 HD12 HG22 ' A' ' 21' ' ' VAL . 10.8 mt -89.06 121.48 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.411 -1.052 . . . . 0.0 108.874 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.527 ' OD1' ' CD1' ' A' ' 4' ' ' TRP . 7.9 t0 -140.39 147.19 39.39 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.357 -0.839 . . . . 0.0 109.933 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -76.6 -39.98 50.92 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.324 -0.86 . . . . 0.0 109.505 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.436 ' OG ' ' HB1' ' A' ' 1' ' ' ALA . 69.3 m -81.94 6.8 14.8 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.281 -0.887 . . . . 0.0 109.224 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 13' ' ' CYS . 9.6 t80 -74.54 121.54 21.7 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.292 -0.88 . . . . 0.0 109.165 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 46' ' ' GLN . . . 109.51 -7.53 32.12 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 13.9 pm0 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.51 -0.994 . . . . 0.0 109.976 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.57 -164.72 0.18 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.209 -0.932 . . . . 0.0 109.452 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -48.87 99.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 109.713 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.635 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 5.9 p-90 -77.33 -21.95 52.64 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 121.207 -0.933 . . . . 0.0 109.568 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.834 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -63.65 -24.37 67.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 0.0 109.48 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -51.1 -31.69 20.06 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.249 -0.907 . . . . 0.0 110.002 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.34 -44.39 54.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 0.0 109.735 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.453 ' HB2' ' CD1' ' A' ' 10' ' ' TYR . 6.7 mt-30 -89.58 -25.08 21.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 0.0 109.715 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.09 45.6 0.86 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.834 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 44.8 m-85 -115.45 163.11 16.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -1.192 . . . . 0.0 108.864 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -75.23 -150.49 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.068 -1.02 . . . . 0.0 110.904 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.481 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 9.3 m -147.44 131.5 17.27 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.573 ' O ' ' CE2' ' A' ' 44' ' ' TYR . 5.0 m -71.6 137.03 47.66 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.096 -1.003 . . . . 0.0 110.306 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -80.61 129.75 34.7 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 59.63 90.03 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.136 -0.978 . . . . 0.0 108.854 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.487 ' HG3' ' O ' ' A' ' 41' ' ' ASP . 35.3 Cg_endo -77.41 -26.58 7.18 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.666 2.244 . . . . 0.0 111.007 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.5 p -72.58 0.34 10.78 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.266 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 89.5 p -142.08 28.61 1.7 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.901 -1.124 . . . . 0.0 110.124 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.62 HG22 HD11 ' A' ' 40' ' ' ILE . 3.0 m -120.27 96.91 5.34 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.002 -1.061 . . . . 0.0 109.448 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.44 ' O ' ' OE2' ' A' ' 22' ' ' GLU . 28.8 mtmt -46.23 119.46 2.34 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.29 -0.881 . . . . 0.0 109.13 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.806 HG22 HD12 ' A' ' 40' ' ' ILE . 40.3 t -70.08 126.66 30.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.503 -0.748 . . . . 0.0 110.449 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.44 ' OE2' ' O ' ' A' ' 20' ' ' LYS . 6.9 mm-40 -109.02 -21.75 12.48 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.661 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.98 167.51 9.79 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.637 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.1 m -170.81 109.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.572 ' OD1' ' CE2' ' A' ' 23' ' ' TYR . 3.5 m-20 -148.6 -165.18 2.2 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.773 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.33 -5.47 14.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.21 -0.931 . . . . 0.0 108.847 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.635 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.4 m -90.86 7.45 39.88 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.342 -0.849 . . . . 0.0 109.169 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.25 -127.81 9.36 Favored Glycine 0 N--CA 1.483 1.782 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.637 ' HG2' HG23 ' A' ' 24' ' ' THR . 55.6 mt-30 -129.22 150.06 50.76 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.651 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -128.15 179.27 5.69 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.952 -1.092 . . . . 0.0 109.826 -179.151 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.463 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.22 153.36 21.49 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.863 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 37.1 t -107.85 134.54 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.983 -1.304 . . . . 0.0 109.208 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.527 ' CG ' ' O ' ' A' ' 32' ' ' VAL . 73.1 mt-30 -159.72 144.6 15.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.548 -0.72 . . . . 0.0 109.582 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.526 ' CB ' ' OE1' ' A' ' 36' ' ' GLN . 0.9 OUTLIER 59.42 14.99 4.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.76 34.61 62.52 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.526 ' OE1' ' CB ' ' A' ' 34' ' ' ASN . 0.3 OUTLIER -145.94 148.55 32.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.153 -1.204 . . . . 0.0 109.722 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.863 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.3 m95 -78.27 136.75 37.82 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.911 0.862 . . . . 0.0 112.041 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.495 ' HB2' ' N ' ' A' ' 13' ' ' CYS . 28.3 p -131.39 146.24 52.18 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.59 123.02 6.31 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.806 HD12 HG22 ' A' ' 21' ' ' VAL . 6.2 mt -89.28 118.07 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.362 -1.081 . . . . 0.0 109.035 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.487 ' O ' ' HG3' ' A' ' 16' ' ' PRO . 24.7 t70 -128.81 137.98 51.81 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.386 -0.821 . . . . 0.0 109.368 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -72.94 -36.94 67.3 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.145 -0.972 . . . . 0.0 109.411 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.39 -10.41 59.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.222 -0.924 . . . . 0.0 108.987 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.573 ' CE2' ' O ' ' A' ' 13' ' ' CYS . 10.9 t80 -75.93 136.82 40.07 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.377 -0.827 . . . . 0.0 109.158 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.45 -55.36 0.17 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.245 -1.15 . . . . 0.0 109.439 -179.955 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.401 ' C ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.401 ' OG ' ' C ' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -179.59 -163.85 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -0.912 . . . . 0.0 109.56 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -43.38 102.78 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.798 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.632 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 6.4 p-90 -77.17 -25.57 52.04 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 109.726 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.823 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -60.36 -24.13 64.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.405 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.77 -32.56 52.85 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.103 -0.998 . . . . 0.0 109.734 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.3 t -45.63 -41.32 10.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.315 -0.865 . . . . 0.0 109.524 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -94.04 -33.39 13.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.914 . . . . 0.0 109.669 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.74 28.66 1.25 Allowed Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.703 -1.236 . . . . 0.0 110.248 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.823 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 46.7 m-85 -95.56 166.99 11.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.084 -1.245 . . . . 0.0 108.946 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 11' ' ' ASN . 1.5 m120 -79.47 -151.17 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.001 -1.062 . . . . 0.0 110.956 -178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.504 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 30.6 m -145.28 133.99 22.24 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.582 ' O ' ' CE2' ' A' ' 44' ' ' TYR . 6.6 m -73.02 138.46 45.98 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.129 -0.982 . . . . 0.0 110.425 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.2 m-20 -77.9 134.54 37.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 48.41 80.45 0.3 Allowed Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 120.963 -1.086 . . . . 0.0 108.429 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.421 ' CB ' HG23 ' A' ' 40' ' ' ILE . 34.9 Cg_endo -76.4 -15.45 17.75 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.695 2.264 . . . . 0.0 110.861 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -70.83 -3.14 17.46 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.128 -0.983 . . . . 0.0 109.937 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 93.9 p -146.81 29.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.078 -1.014 . . . . 0.0 109.925 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.659 HG22 HD11 ' A' ' 40' ' ' ILE . 3.4 m -106.78 98.78 8.4 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.145 -0.972 . . . . 0.0 109.325 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 19' ' ' THR . 14.7 mttt -43.52 119.0 1.5 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.395 -0.816 . . . . 0.0 109.179 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.784 HG22 HD12 ' A' ' 40' ' ' ILE . 42.8 t -73.29 124.29 30.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 110.834 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.93 -21.76 12.7 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.655 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.16 167.45 10.0 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.586 HG23 ' HG2' ' A' ' 29' ' ' GLN . 1.3 m -170.78 109.03 0.32 Allowed 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.43 -167.53 2.81 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.396 -0.921 . . . . 0.0 109.685 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.36 -6.07 12.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.011 . . . . 0.0 108.87 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.632 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.5 m -89.69 7.61 35.81 Favored 'General case' 0 C--N 1.308 -1.203 0 O-C-N 121.326 -0.859 . . . . 0.0 109.076 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.3 -129.73 9.99 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.348 -1.901 . . . . 0.0 108.348 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.586 ' HG2' HG23 ' A' ' 24' ' ' THR . 61.2 mt-30 -127.04 150.02 49.64 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.649 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -128.35 178.54 6.2 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.907 -1.121 . . . . 0.0 109.806 -179.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -136.01 154.66 22.0 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.199 -1.96 . . . . 0.0 108.199 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.826 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 41.6 t -106.97 139.67 27.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 120.841 -1.387 . . . . 0.0 109.068 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 1.2 mp0 -162.24 139.15 8.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.488 -0.757 . . . . 0.0 109.536 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.95 13.03 5.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.46 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.05 30.4 59.17 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 33' ' ' GLN . 4.5 pt20 -141.16 146.32 36.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.154 -1.203 . . . . 0.0 109.63 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.826 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.4 m95 -76.53 137.28 39.49 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.843 0.83 . . . . 0.0 112.024 -179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.504 ' HB2' ' C ' ' A' ' 12' ' ' CYS . 29.7 p -131.17 147.7 52.63 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -87.13 123.33 6.52 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.784 HD12 HG22 ' A' ' 21' ' ' VAL . 6.2 mt -90.51 117.7 34.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.302 -1.117 . . . . 0.0 108.955 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -137.88 148.04 45.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.396 -0.815 . . . . 0.0 109.766 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -78.04 -34.69 50.42 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.337 -0.852 . . . . 0.0 109.523 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.465 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 0.3 OUTLIER -75.91 -0.33 21.01 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.336 179.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.582 ' CE2' ' O ' ' A' ' 13' ' ' CYS . 22.3 t80 -80.0 150.91 30.27 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.318 -0.864 . . . . 0.0 109.154 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.01 56.31 17.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' HG3' ' O ' ' A' ' 43' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.265 -1.138 . . . . 0.0 109.502 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.524 ' CB ' ' OD2' ' A' ' 41' ' ' ASP . 66.8 m -83.4 9.1 11.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.553 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -65.12 106.52 1.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.554 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.631 ' CZ3' ' CB ' ' A' ' 27' ' ' SER . 7.1 p-90 -76.76 -26.38 54.48 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.16 -0.962 . . . . 0.0 109.808 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.776 ' HB1' ' HB2' ' A' ' 10' ' ' TYR . . . -64.09 -22.87 67.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.2 -0.938 . . . . 0.0 109.474 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.529 ' CG ' ' N ' ' A' ' 7' ' ' SER . 6.6 pt20 -53.75 -44.8 70.26 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.529 ' N ' ' CG ' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -46.01 -35.35 4.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 110.014 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -90.75 -29.97 17.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.056 -1.027 . . . . 0.0 109.922 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.25 39.33 0.95 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.776 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 49.9 m-85 -116.34 161.09 19.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -1.199 . . . . 0.0 108.923 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -73.75 -150.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.09 -1.006 . . . . 0.0 110.947 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.471 ' C ' ' HB2' ' A' ' 38' ' ' CYS . 24.7 m -147.08 132.5 18.61 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.579 ' O ' ' CE2' ' A' ' 44' ' ' TYR . 5.0 m -73.67 133.94 43.51 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.191 -0.943 . . . . 0.0 110.382 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -76.74 132.02 39.06 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.7 m120 55.54 91.05 0.08 OUTLIER Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.055 -1.028 . . . . 0.0 108.821 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.555 ' HB3' HG23 ' A' ' 40' ' ' ILE . 35.1 Cg_endo -77.25 -28.72 5.5 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.705 2.27 . . . . 0.0 110.877 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.13 -2.71 13.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 110.137 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.8 34.46 1.98 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 0.0 110.095 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.558 HG22 HD11 ' A' ' 40' ' ' ILE . 2.1 m -125.51 96.63 4.87 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.981 -1.075 . . . . 0.0 109.36 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 19' ' ' THR . 9.1 mttm -44.61 117.74 1.38 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.396 -0.815 . . . . 0.0 109.196 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.94 HG22 HD12 ' A' ' 40' ' ' ILE . 38.9 t -73.29 126.94 34.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 O-C-N 121.454 -0.779 . . . . 0.0 110.712 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.466 ' OE1' ' HB ' ' A' ' 32' ' ' VAL . 0.4 OUTLIER -108.85 -20.86 12.91 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 177.681 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.661 ' HB2' ' CZ3' ' A' ' 37' ' ' TRP . 1.1 t80 -102.99 166.64 10.33 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -170.87 109.02 0.32 Allowed 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 177.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 24' ' ' THR . 26.7 m-20 -147.32 -167.31 2.75 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.591 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.29 -6.13 12.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 108.814 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.631 ' CB ' ' CZ3' ' A' ' 4' ' ' TRP . 1.4 m -88.2 6.94 34.27 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.352 -0.842 . . . . 0.0 109.145 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.83 -126.08 8.8 Favored Glycine 0 N--CA 1.484 1.877 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.608 ' HB3' HG21 ' A' ' 21' ' ' VAL . 9.7 mt-30 -128.99 152.62 48.4 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.653 ' HB2' ' CB ' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -131.76 174.29 10.29 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.907 -1.121 . . . . 0.0 109.751 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' SG ' ' A' ' 38' ' ' CYS . . . -132.71 153.34 20.62 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.884 HG23 ' CZ3' ' A' ' 37' ' ' TRP . 25.1 t -107.85 131.71 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.995 -1.297 . . . . 0.0 109.101 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.51 ' O ' ' CG ' ' A' ' 36' ' ' GLN . 44.0 mt-30 -150.33 132.8 15.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -0.766 . . . . 0.0 109.564 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.466 ' HB3' ' HG2' ' A' ' 36' ' ' GLN . 13.1 t-20 63.02 16.01 8.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.311 -0.868 . . . . 0.0 109.413 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.39 28.16 64.32 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.51 ' CG ' ' O ' ' A' ' 33' ' ' GLN . 0.8 OUTLIER -132.49 142.5 49.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.151 -1.205 . . . . 0.0 109.541 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.884 ' CZ3' HG23 ' A' ' 32' ' ' VAL . 1.3 m95 -78.05 135.08 37.68 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.856 0.836 . . . . 0.0 111.976 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.471 ' HB2' ' C ' ' A' ' 12' ' ' CYS . 28.6 p -130.35 147.71 52.09 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.02 122.17 6.32 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.94 HD12 HG22 ' A' ' 21' ' ' VAL . 8.0 mt -88.3 120.33 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.401 -1.058 . . . . 0.0 108.967 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.524 ' OD2' ' CB ' ' A' ' 2' ' ' SER . 26.7 t70 -129.6 134.84 47.93 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.439 -0.788 . . . . 0.0 109.1 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 46' ' ' GLN . 5.9 m-85 -69.61 -36.79 76.49 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.191 -0.943 . . . . 0.0 109.485 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.483 ' HB3' ' HB3' ' A' ' 2' ' ' SER . 47.9 t -76.7 -9.64 58.81 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.927 . . . . 0.0 109.062 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.579 ' CE2' ' O ' ' A' ' 13' ' ' CYS . 8.4 t80 -76.04 115.7 16.0 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.366 -0.834 . . . . 0.0 109.17 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.59 -11.43 61.61 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 1.6 mt-30 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.19 -1.182 . . . . 0.0 109.423 179.991 . . . . . . . . 1 1 . 1 stop_ save_